{"study_id": 186347, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the influence of curcumin-containing supplements on biomarkers of inflammation and oxidative stress through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "Curcumin supplementation significantly reduced interleukin 6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and malondialdehyde (MDA) levels, indicating anti-inflammatory and antioxidant effects, but had no significant impact on tumor necrosis factor-alpha or superoxide dismutase levels.", "population_specificity": "Not specified (general population from included RCTs)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:08.705896+00:00"}
{"study_id": 186348, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to determine whether perioperative oral curcumin could reduce inflammation and postrepair complications in patients undergoing elective abdominal aortic aneurysm repair.", "results_summary": "The study found no significant effect of curcumin on the measured biomarkers of injury and inflammation, indicating no beneficial effects for the intended outcomes. The results highlight the need for rigorous testing of curcumin's health claims.", "population_specificity": "Patients scheduled for elective repair of unruptured abdominal aortic aneurysms (median age 76 years).", "effective_dosage": "2000-mg doses, 8 times over 4 days.", "study_duration": "4 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:09.270986+00:00"}
{"study_id": 186352, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of curcumin intake on glycemic control and lipid profiles in patients with metabolic syndrome (MetS) and related disorders.", "results_summary": "Curcumin intake significantly reduced fasting glucose, HOMA-IR, HbA1c, triglycerides, and total cholesterol levels but increased insulin levels. No significant effects were observed on LDL- and HDL-cholesterol levels.", "population_specificity": "Patients with metabolic syndrome (MetS) and related disorders (1,890 participants across 26 trials).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:09.332519+00:00"}
{"study_id": 186351, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 70, "study_goal": "The researchers aimed to determine whether 3 days of curcumin supplementation affects peripheral blood mononuclear cell (PBMC) responses to exertional heat stress in non-heat-acclimated humans.", "results_summary": "Curcumin did not alter PBMC protein expression compared to placebo. However, both conditions showed reductions in TLR4, HSP70, pAMPK, and SIRT1 post-exercise, while the pNF-\u03baB/NF-\u03baB ratio increased, suggesting maintained inflammatory capacity.", "population_specificity": "Non-heat-acclimated humans", "effective_dosage": "500 mg/day", "study_duration": "3 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:09.677007+00:00"}
{"study_id": 186353, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine the role of curcumin in reducing inflammatory responses mediated by TNF-\u03b1 and NF-\u03bab signaling in neurodegenerative diseases.", "results_summary": "Curcumin was found to reduce inflammatory responses mediated by TNF-\u03b1, suggesting therapeutic potential for neuroinflammatory diseases like Alzheimer's and Parkinson's. The study highlights curcumin's anti-inflammatory properties but does not provide specific clinical trial data.", "population_specificity": "Neurodegenerative disease models (e.g., Alzheimer's, Parkinson's, multiple sclerosis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:10.112496+00:00"}
{"study_id": 186354, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether unformulated curcumin and phospholipidated curcumin could reduce anti-Hsp 27 antibody titers in patients with metabolic syndrome (MetS).", "results_summary": "The study found no significant differences in changes to serum anti-Hsp 27 concentrations between the curcumin, phospholipidated curcumin, and placebo groups after 6 weeks of treatment.", "population_specificity": "120 patients with metabolic syndrome (diagnosed by IDF criteria).", "effective_dosage": "1 g/d curcumin or phospholipidated curcumin.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:12.129724+00:00"}
{"study_id": 186355, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the combined effects of \u03c9-3 fatty acids and nano-curcumin on IL-6 gene expression and serum levels, as well as hs-CRP levels, in migraine patients.", "results_summary": "Nano-curcumin and \u03c9-3 fatty acids down-regulated IL-6 mRNA and significantly decreased serum IL-6 and hs-CRP levels, with the combination group showing additive effects. The results suggest a potential synergistic relationship between the two supplements.", "population_specificity": "Eighty episodic migraine patients.", "effective_dosage": "80 mg nano-curcumin daily.", "study_duration": "Two months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:12.632967+00:00"}
{"study_id": 186357, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential cognitive benefits of curcumin supplementation in humans, particularly its anti-inflammatory effects and impact on cognitive decline.", "results_summary": "Two out of five randomized controlled trials showed beneficial effects of curcumin on cognition, specifically improving working memory, but methodological limitations and lack of inflammatory biomarker analysis hindered conclusive results.", "population_specificity": "Older adults, both cognitively unimpaired and impaired.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:16.417653+00:00"}
{"study_id": 186356, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the most recent in vitro investigations, clinical trials, and patents related to curcumin's antitumor effects to provide an updated overview of its potential as a dietary supplement.", "results_summary": "The study found that curcumin exhibits antioxidant, anti-inflammatory, and antitumor properties, with demonstrated efficacy in preclinical and clinical trials. It activates apoptosis pathways, inhibits inflammation, angiogenesis, and metastasis, and shows potential as a radio/chemosensitizer with low side effects.", "population_specificity": "Healthy and oncological populations (not further specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:17.465693+00:00"}
{"study_id": 186359, "supplement_id": 1062, "safety_score": "90", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Phytoproflex\u00ae, a curcumin-containing supplement, in managing symptoms and oxidative stress in patients with knee osteoarthritis.", "results_summary": "The study found that Phytoproflex\u00ae significantly reduced pain, improved functional capacity, decreased oxidative stress, and reduced the need for rescue medication in OA patients compared to controls. No safety or tolerability issues were reported.", "population_specificity": "56 patients with knee osteoarthritis (24 received the supplement).", "effective_dosage": "Not specified (supplement contained boswellic acid 90%, curcumin 20%, and valeric acid 0.8%).", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:18.484959+00:00"}
{"study_id": 186361, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the mechanism by which curcumin, despite negligible absorption, beneficially modulates metabolic and neurological diseases by maintaining intestinal barrier integrity and reducing circulating LPS.", "results_summary": "The study found that curcumin decreases gut bacteria-derived LPS release into circulation by preserving intestinal barrier function, thereby attenuating metabolic diseases like diabetes, atherosclerosis, and kidney disease without requiring systemic absorption. This mechanism explains curcumin's broad anti-inflammatory and disease-modulating effects.", "population_specificity": "Not specified (mechanistic review, not a clinical trial).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:18.607461+00:00"}
{"study_id": 186363, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review studies on the effects of curcumin in experimental models (in vivo and in vitro) for Alzheimer's disease.", "results_summary": "Curcumin supplementation reversed neurotoxic and behavioral damages in both in vivo and in vitro models of Alzheimer's disease, suggesting it as a promising therapeutic approach.", "population_specificity": "Experimental models (in vivo and in vitro) of Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:19.640843+00:00"}
{"study_id": 186358, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to investigate the bioavailability of curcumin when combined with resveratrol and its acute effects on postprandial inflammatory responses in abdominally obese individuals.", "results_summary": "The study found that curcumin combined with resveratrol did not significantly alter most postprandial inflammatory markers but reduced the cumulative response of sVCAM-1. No significant changes in gene expression (PPARA and NFKB1) were observed.", "population_specificity": "11 men and 11 postmenopausal women with abdominal obesity (mean age 62 \u00b1 5 years, BMI 29 \u00b1 3 kg/m\u00b2).", "effective_dosage": "100 mg curcumin combined with 200 mg resveratrol, administered once.", "study_duration": "Acute (single dose, measured over 6 hours).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:19.703530+00:00"}
{"study_id": 186362, "supplement_id": 1062, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of turmeric (Curcumin) on reducing inflammatory markers in hemodialysis patients.", "results_summary": "Turmeric significantly reduced hs-CRP, IL-6, and TNF-\u03b1 levels and increased albumin levels, but no statistical difference was observed between the intervention and control groups. No adverse effects or meaningful changes in potassium or liver function tests were reported.", "population_specificity": "Hemodialysis patients over 18 years old.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:20.126673+00:00"}
{"study_id": 186364, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of curcumin supplementation on anthropometric variables, particularly weight reduction, through a systematic review of randomized controlled trials.", "results_summary": "Five studies using regular curcumin showed no significant effect on anthropometric measures, while three studies using more bioavailable forms or longer intervention durations reported significant weight reduction effects. The results suggest that bioavailable curcumin may help reduce obesity and overweight, but more research is needed.", "population_specificity": "Human adults", "effective_dosage": "Not specified", "study_duration": "Varied (not specified, but longer durations showed significant effects)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:25.920835+00:00"}
{"study_id": 186367, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the synergistic effects of omega-3 fatty acids and nano-curcumin on ICAM-1 gene expression and serum levels in migraine patients.", "results_summary": "The study found no significant change in ICAM-1 gene expression but observed a significant reduction in ICAM-1 serum levels in the combination group and omega-3 alone. Additionally, the combination group showed a significant reduction in migraine attack frequency.", "population_specificity": "72 episodic migraine patients", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:26.399666+00:00"}
{"study_id": 186365, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of curcumin supplementation on adiponectin, leptin, and ghrelin levels in patients with type 2 diabetes.", "results_summary": "Curcumin supplementation significantly increased adiponectin levels and reduced leptin levels, the leptin:adiponectin ratio, and TNF-\u03b1 levels, but did not affect ghrelin levels. These changes suggest anti-inflammatory effects independent of weight change.", "population_specificity": "118 patients with type 2 diabetes (50 control and 50 active subjects completed the trial).", "effective_dosage": "1000mg curcumin with 10mg piperine daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:26.927429+00:00"}
{"study_id": 186371, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether short-term dietary curcumin supplementation reduces gastrointestinal barrier damage and physiological strain responses during exertional heat stress in humans.", "results_summary": "The study found that 3 days of 500 mg/day curcumin supplementation reduced gastrointestinal barrier damage and physiological strain responses during exertional heat stress in non-heat-acclimated participants.", "population_specificity": "Non-heat-acclimated humans", "effective_dosage": "500 mg/day", "study_duration": "3 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:27.743312+00:00"}
{"study_id": 186368, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether curcumin nanomicelle supplementation could improve semen parameters and inflammatory markers in infertile men.", "results_summary": "The study found that curcumin nanomicelle supplementation significantly improved total sperm count, sperm concentration, motility, and plasma levels of total antioxidant capacity, malondialdehyde, C-reactive protein, and tumor necrosis factor \u03b1 compared to placebo. These improvements were statistically significant both relative to baseline and the control group.", "population_specificity": "60 infertile men (28 completed per group) from a urology unit of an infertility clinic.", "effective_dosage": "80 mg curcumin nanomicelle daily", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:27.760590+00:00"}
{"study_id": 186370, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Infla-Kine, containing an enhanced absorption bio-curcumin complex (BCM-95), reduces inflammatory markers and improves quality of life in healthy volunteers.", "results_summary": "After 4 weeks, Infla-Kine significantly reduced transcripts of IL8, IL-6, NF-\u03baB, and TNF-\u03b1 in PBMCs, with non-significant reductions in IL-1b and CRP. Quality of life improvements were most notable in muscle and joint pains.", "population_specificity": "24 healthy volunteers", "effective_dosage": "Twice daily (specific dosage not provided)", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:28.557687+00:00"}
{"study_id": 186369, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the impact of curcuminoids on serum lipid levels through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found that curcuminoid therapy significantly reduced plasma triglycerides and increased HDL-C levels, but did not significantly alter LDL-C or total cholesterol levels. The effects were not dependent on the duration of supplementation.", "population_specificity": "1,427 participants across 20 randomized controlled trials.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:28.675751+00:00"}
{"study_id": 186360, "supplement_id": 1062, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to critically summarize recent clinical studies evaluating the potential health benefits of curcumin consumption in promoting human health and preventing chronic diseases.", "results_summary": "Curcumin consumption showed potential benefits against obesity, metabolic syndrome, diabetes, cancer, fatty liver disease, depression, arthritis, skin diseases, gut inflammation, and premenstrual syndrome, though heterogeneity in study designs prevented definitive conclusions.", "population_specificity": "Individuals with various chronic diseases (e.g., obesity, metabolic syndrome, diabetes, cancer, etc.).", "effective_dosage": "Not specified (strong heterogeneity in effective dose and formulation).", "study_duration": "Not specified (heterogeneity in recommended treatment duration).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:29.454451+00:00"}
{"study_id": 186372, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether turmeric extract, curcuminoids, or isolated curcumin supplementation is more effective than placebo in reducing fasting blood glucose (FBG) in adults.", "results_summary": "The meta-analysis found that curcumin supplementation was effective in decreasing FBG compared to placebo, though specific effect sizes and statistical significance were not detailed in the abstract. Secondary outcomes included HbA1c, but results were not fully described.", "population_specificity": "Adults over 18 years with dysglycemia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Follow-up \u22654 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:35.318736+00:00"}
{"study_id": 186377, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review the mechanisms of natural autophagy inducers, including curcumin, and their potential as supplements or alternative medicines for cancer therapy.", "results_summary": "The study suggests curcumin may act as an autophagy inducer, potentially triggering cell death in cancer therapy, but further preclinical and clinical investigation is warranted.", "population_specificity": "Not specified (general cancer therapy context)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:35.955669+00:00"}
{"study_id": 186373, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of curcumin supplementation on markers of oxidative stress in patients with \u03b2-thalassemia major.", "results_summary": "Curcumin supplementation significantly reduced serum malondialdehyde (MDA), total and direct bilirubin, and increased total antioxidant capacity. No significant changes were observed in hemoglobin, serum iron, ferritin, catalase, or vitamin E levels.", "population_specificity": "\u03b2-thalassemia major patients (n=61)", "effective_dosage": "Two 500 mg curcumin capsules daily (total 1000 mg/day)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:35.989807+00:00"}
{"study_id": 186376, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether curcuminoids, combined with piperine, could improve serum lipid profiles in patients with type 2 diabetes.", "results_summary": "The study found that curcuminoids significantly reduced total cholesterol, non-HDL-C, and Lp(a), while increasing HDL-C levels, but did not significantly affect triglycerides or LDL-C compared to placebo.", "population_specificity": "Patients with type 2 diabetes (n=118).", "effective_dosage": "1000 mg/day curcuminoids plus 10 mg/day piperine.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:36.036497+00:00"}
{"study_id": 186374, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether curcumin affects leptin levels in humans through a meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found a significant decrease in plasma leptin concentrations following curcumin treatment, with a standardized mean difference of -0.69 (95% CI: -1.16, -0.23, p = 0.003).", "population_specificity": "Not specified in the abstract (likely general or metabolic disease populations based on context).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:36.105109+00:00"}
{"study_id": 186375, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of curcumin supplementation on serum pro-oxidant-antioxidant balance (PAB) in patients with metabolic syndrome (MetS).", "results_summary": "Serum PAB increased significantly in the curcumin group but not in the phospholipidated curcumin group. The study did not find any improvement in PAB following curcumin supplementation in MetS subjects.", "population_specificity": "Patients with metabolic syndrome (n = 120).", "effective_dosage": "1 g/day of simple curcumin or 1 g/day of phospholipidated curcumin (containing 200 mg of pure curcumin).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:36.693783+00:00"}
{"study_id": 186379, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of curcumin on oxidative stress and histological changes in chronic gastritis associated with H. pylori.", "results_summary": "Triple therapy with curcumin significantly reduced oxidative stress markers, improved antioxidant capacity, decreased DNA damage, and reduced inflammation scores compared to triple therapy alone. It also increased the H. pylori eradication rate.", "population_specificity": "Patients with chronic gastritis associated with H. pylori.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:36.860522+00:00"}
{"study_id": 186378, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential additive and synergistic effects of Curcumin, either alone or in combination, with conventional chemotherapy for chronic lymphocytic leukemia (CLL).", "results_summary": "The study found that Curcumin, when used as monotherapy or in combination, has additive and synergistic effects with conventional chemotherapy for CLL. However, specific efficacy data for Curcumin alone were not detailed.", "population_specificity": "Patients with chronic lymphocytic leukemia (CLL), including early-stage and relapsed/refractory cases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:36.865894+00:00"}
{"study_id": 186381, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess curcumin's potential as an inexpensive, well-tolerated, and safe agent for improving endothelial function.", "results_summary": "Curcumin demonstrated anti-inflammatory, antioxidant, anti-hypertensive, and other beneficial effects by modulating endothelial cell markers and reducing oxidative stress. It improved endothelial function, though precise mechanisms and biomarkers require further research.", "population_specificity": "Not specified (literature review).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:43.619891+00:00"}
{"study_id": 186380, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the synergistic effects of \u03c9-3 fatty acids and nano-curcumin on TNF-\u03b1 gene expression and serum levels in migraine patients.", "results_summary": "The combination of \u03c9-3 fatty acids and nano-curcumin significantly downregulated TNF-\u03b1 mRNA and reduced serum levels synergistically, with a greater reduction in migraine attack frequency. Neither supplement alone showed significant effects on TNF-\u03b1 mRNA or serum levels.", "population_specificity": "74 episodic migraine patients divided into 4 groups.", "effective_dosage": "Not specified in the abstract.", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:43.868293+00:00"}
{"study_id": 186385, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to summarize current knowledge on the impact of curcumin supplementation on biochemical and histopathological features of NAFLD.", "results_summary": "Curcumin demonstrated lipid-modifying, antioxidant, anti-inflammatory, insulin-sensitizing, anti-steatotic, and anti-fibrotic properties in experimental models of NAFLD, but clinical evidence remains limited.", "population_specificity": "Patients with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:44.024452+00:00"}
{"study_id": 186383, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of phytosomal curcumin supplementation in subjects with non-alcoholic fatty liver disease (NAFLD).", "results_summary": "Curcumin supplementation was associated with reductions in body mass index and improvements in hepatic enzymes and liver ultrasonography findings compared to placebo. The study suggests curcumin may have beneficial effects on NAFLD-related parameters.", "population_specificity": "Patients diagnosed with NAFLD (grades 1-3 via liver ultrasonography).", "effective_dosage": "1,000 mg/day in 2 divided doses (phytosomal form).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:44.549539+00:00"}
{"study_id": 186384, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether curcumin improves resistance and conduit artery endothelial function and reduces large elastic artery stiffness in healthy middle-aged and older adults.", "results_summary": "The study compared 12 weeks of curcumin supplementation (2000 mg/day) to placebo in healthy adults, measuring forearm blood flow response to acetylcholine infusions. The abstract does not provide specific results on efficacy, but the study design suggests an investigation into vascular function improvements.", "population_specificity": "Healthy middle-aged and older men and postmenopausal women (45-74 years).", "effective_dosage": "2000 mg/day (Longvida\u00ae).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:44.815102+00:00"}
{"study_id": 186386, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of curcumin supplementation on serum cytokine concentrations in subjects with metabolic syndrome (MetS).", "results_summary": "Curcumin supplementation significantly reduced serum concentrations of TNF-\u03b1, IL-6, TGF-\u03b2, and MCP-1 compared to placebo, with most changes remaining significant after adjusting for confounders. The placebo group showed only a reduction in TGF-\u03b2, while other cytokines remained unchanged.", "population_specificity": "Males and females diagnosed with metabolic syndrome (MetS) according to National Cholesterol Education Program Adult Treatment Panel III guidelines.", "effective_dosage": "1g/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:45.363094+00:00"}
{"study_id": 186382, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether curcumin supplementation could improve serum vitamin E levels in subjects with metabolic syndrome (MetS).", "results_summary": "The study found that curcumin had no improving effect on serum vitamin E levels (p > 0.05). However, there were significant changes in vitamin E ratios with cholesterol and triglycerides between the groups (p < 0.05 to p < 0.01).", "population_specificity": "120 subjects aged 18-65 years with metabolic syndrome (MetS) according to International Diabetic Federation Criteria.", "effective_dosage": "Lecithinized curcumin (1 g/day, equivalent to 200 mg pure curcumin/day) and unformulated curcumin (1 g/day).", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:45.431567+00:00"}
{"study_id": 186387, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of curcuminoids supplementation in reducing circulating IL-6 concentrations through a meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found a significant reduction in circulating IL-6 concentrations following curcuminoids supplementation, with a weighted mean difference of -0.60 pg/mL. The effect was more pronounced in patients with higher baseline IL-6 levels, indicating greater efficacy in individuals with systemic inflammation.", "population_specificity": "Patients included in randomized controlled trials assessing IL-6 levels (specific conditions not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:45.724484+00:00"}
{"study_id": 186388, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate curcumin's potential to improve insulin resistance (IR) and related diseases, assessing factors influencing its clinical effects.", "results_summary": "The study found that curcumin may improve IR by modulating insulin receptor pathways, but results are inconclusive due to variability in dosage, treatment duration, and curcumin type. Some clinical evidence suggests beneficial effects on IR-related conditions.", "population_specificity": "Individuals with insulin resistance-related conditions such as diabetes, metabolic syndrome, and obesity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:51.415509+00:00"}
{"study_id": 186390, "supplement_id": 1062, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether curcumin in turmeric extract, combined with turmerones or bevacizumab, enhances anti-tumor effects in colorectal cancer.", "results_summary": "Turmeric extract improved curcumin bioavailability and, when combined with bevacizumab, significantly inhibited tumor growth in mice, with effects comparable to FOLFOX but without observable side effects.", "population_specificity": "HT29 colon tumor-bearing mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Combined use with bevacizumab was studied, showing enhanced efficacy.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:51.801295+00:00"}
{"study_id": 186389, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effect of curcumin on circulating adiponectin and leptin concentrations in patients with metabolic syndrome.", "results_summary": "Eight-week curcumin supplementation significantly increased serum adiponectin levels and reduced serum leptin concentrations, improving the leptin:adiponectin ratio. These effects remained significant after adjusting for potential confounders, though the meta-analysis showed a non-significant reduction in leptin levels.", "population_specificity": "Patients with metabolic syndrome according to the National Cholesterol Education Program Adult Treatment Panel III criteria.", "effective_dosage": "1000 mg/d", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:52.376898+00:00"}
{"study_id": 186391, "supplement_id": 1062, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "To assess the effects of curcumin on metabolic profile (lipid levels, glucose control, uric acid) in subjects with NAFLD.", "results_summary": "Curcumin supplementation significantly reduced serum levels of total cholesterol, LDL cholesterol, triglycerides, non-HDL cholesterol, and uric acid, but did not affect HDL cholesterol or glucose control parameters. It was safe and well tolerated.", "population_specificity": "Patients diagnosed with NAFLD (grades 1-3).", "effective_dosage": "1000 mg/d in 2 divided doses.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:52.758926+00:00"}
{"study_id": 186392, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of curcumin supplementation on reducing circulating levels of TNF-\u03b1 in randomized controlled trials.", "results_summary": "The meta-analysis found a significant reduction in circulating TNF-\u03b1 concentrations following curcumin supplementation, with a robust effect size confirmed by sensitivity analysis. No significant association was found between the TNF-\u03b1-lowering effects and either dose or duration of treatment.", "population_specificity": "Participants in randomized controlled trials (specific population details not provided in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:52.855146+00:00"}
{"study_id": 186395, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore how nutritional interventions like curcumin supplementation might mitigate diet-induced cognitive decline.", "results_summary": "The abstract suggests that curcumin supplementation has positive effects on cognitive function in healthy aging humans and disease states, potentially attenuating diet-induced cognitive decline. The study highlights inflammation and BDNF as key mechanisms.", "population_specificity": "Healthy aging humans and individuals with disease states.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:53.339289+00:00"}
{"study_id": 186394, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of curcumin supplementation on oxidative status in prostate cancer patients undergoing radiotherapy.", "results_summary": "Curcumin supplementation significantly increased total antioxidant capacity (TAC) and reduced superoxide dismutase (SOD) activity compared to placebo, but no significant differences were observed in treatment outcomes (PSA levels) between groups.", "population_specificity": "40 prostate cancer patients undergoing radiotherapy (20 in curcumin group, 20 in placebo group).", "effective_dosage": "3 g/day (total daily dose).", "study_duration": "During external-beam radiation therapy (up to 74 Gy).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:53.998710+00:00"}
{"study_id": 186393, "supplement_id": 1062, "safety_score": "80", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of curcumin supplementation on redox status and Nrf2 activation in patients with nondiabetic or diabetic proteinuric chronic kidney disease.", "results_summary": "Curcumin did not improve proteinuria, kidney function, or lipid profile but reduced lipid peroxidation in nondiabetic patients and enhanced antioxidant capacity in diabetic patients. No effects were observed on antioxidant enzyme activities or Nrf2 activation.", "population_specificity": "Mexican patients (20-70 years) with nondiabetic or diabetic proteinuric chronic kidney disease (proteinuria \u2265 1 g/24 hours).", "effective_dosage": "320 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:54.268809+00:00"}
{"study_id": 186399, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "To investigate the effectiveness of curcumin on reducing symptoms of anxiety and depression in obese individuals.", "results_summary": "Curcumin significantly reduced anxiety scores (BAI) but had no significant effect on depression scores (BDI).", "population_specificity": "30 obese individuals", "effective_dosage": "1 g/day", "study_duration": "30 days per intervention phase, with a 2-week washout period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:59.508878+00:00"}
{"study_id": 186396, "supplement_id": 1062, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to clarify the antidepressant actions of curcumin and its underlying mechanisms in depressed patients, as well as its potential to enhance antidepressant treatment outcomes.", "results_summary": "Curcumin supplementation significantly reduced depressive symptoms (measured by HAM-D and MADRS scores), decreased inflammatory cytokines (IL-1\u03b2 and TNF-\u03b1), increased plasma BDNF levels, and lowered salivary cortisol compared to placebo.", "population_specificity": "108 male adults aged 31-59 with major depressive disorder, recruited from Tianjin Anding Hospital.", "effective_dosage": "1000 mg of curcumin daily (2 capsules).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:00.006287+00:00"}
{"study_id": 186397, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore how the degradation and metabolism of curcumin influence its polypharmacology and the interpretation of preclinical and clinical data.", "results_summary": "The study found that curcumin degrades into diverse chemical species, which may explain its wide range of cellular targets and effects. The degradation products could be key to understanding curcumin's polypharmacology.", "population_specificity": "Not specified (preclinical and clinical studies referenced, but no specific population detailed).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:00.387367+00:00"}
{"study_id": 186400, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether curcuminoids could reduce systemic oxidative burden in patients with knee osteoarthritis.", "results_summary": "Curcuminoid supplementation significantly increased serum SOD activities, showed a borderline significant elevation in GSH concentrations, and significantly reduced MDA concentrations compared to placebo, indicating attenuation of oxidative stress.", "population_specificity": "Forty patients with mild-to-moderate primary knee osteoarthritis.", "effective_dosage": "1500 mg/day in 3 divided doses, co-administered with piperine (15 mg/day).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:00.479499+00:00"}
{"study_id": 186398, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To determine the effects of oral curcumin supplementation on muscle damage, inflammation, and delayed onset muscle soreness (DOMS) following unaccustomed heavy eccentric exercise in humans.", "results_summary": "Curcumin moderately to largely reduced pain associated with DOMS and showed small improvements in muscle performance recovery. It also altered interleukin-6 concentrations, decreasing them at 24 hours but increasing them at 0 and 48 hours post-exercise.", "population_specificity": "Seventeen men", "effective_dosage": "2.5 g twice daily", "study_duration": "5 days (2 days before to 3 days after exercise)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:01.301180+00:00"}
{"study_id": 186401, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore potential antidepressant mechanisms of action of curcumin by analyzing biomarkers in individuals with major depressive disorder.", "results_summary": "Curcumin supplementation was associated with elevations in urinary thromboxane B2 and substance P, while placebo reduced aldosterone and cortisol. Higher baseline plasma endothelin-1 and leptin in curcumin-treated individuals correlated with greater reductions in depressive symptoms.", "population_specificity": "50 participants diagnosed with major depressive disorder.", "effective_dosage": "500 mg, twice daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:01.462606+00:00"}
{"study_id": 186402, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the preclinical properties of curcumin and its analogues for their potential anticancer activity in ovarian cancer, particularly in platinum-resistant and multidrug-resistant cases.", "results_summary": "Curcumin demonstrated multifunctional anticancer mechanisms, including synergistic effects with platinum-taxane chemotherapeutics, sensitization of resistant cells, and reduction of effective drug doses. It showed promise as a supportive treatment in ovarian cancer, especially for resistant or recurrent cases, though clinical studies are needed.", "population_specificity": "Preclinical studies involving in vivo and in vitro models of ovarian cancer, particularly platinum-resistant primary epithelial ovarian cancer and multidrug-resistant cancer cells/xenografts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:02.772498+00:00"}
{"study_id": 186403, "supplement_id": 1062, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the clinical effects of curcuminoids on pulmonary function and systemic inflammation in sulfur mustard-intoxicated subjects.", "results_summary": "Curcuminoids significantly improved FEV1/FVC and modulated inflammatory mediators (IL-6, IL-8, TNF\u03b1, TGF\u03b2, substance P, hs-CRP, CGRP, MCP-1) compared to placebo, but did not affect FEV1 or FVC. They were safe and well-tolerated.", "population_specificity": "89 male subjects with chronic sulfur mustard-induced pulmonary complications.", "effective_dosage": "500 mg TID (three times daily) per oral.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:03.533216+00:00"}
{"study_id": 186405, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the effects of exogenous antioxidants, including curcumin, on the lifespan of model organisms and discuss their mechanisms of action.", "results_summary": "The abstract does not provide specific results for curcumin but indicates that antioxidants, including curcumin, may have indirect or non-antioxidant mechanisms affecting lifespan. The legitimacy of antioxidant supplementation in humans is considered.", "population_specificity": "Model organisms (not specified).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:07.922368+00:00"}
{"study_id": 186408, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of dietary components, including curcumin, in reducing pancreatic cancer risk.", "results_summary": "The study suggests that curcumin, along with other flavonoids, should be encouraged in the diet for potential protective effects against pancreatic cancer, though no specific efficacy data or mechanisms are detailed.", "population_specificity": "General population, with a focus on dietary prevention of pancreatic cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:08.833885+00:00"}
{"study_id": 186404, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether MB-6, a botanical preparation containing curcumin, could enhance the effectiveness of chemotherapy in patients with metastatic colorectal cancer.", "results_summary": "MB-6 combined with chemotherapy significantly reduced disease progression rates (0.0% vs 15.8%) and lowered adverse events (grade 4+ events: 2.9% vs 28.9%) compared to placebo, though no significant difference was observed in overall response or survival rates.", "population_specificity": "Patients with metastatic colorectal cancer (72 participants in the clinical study).", "effective_dosage": "Not specified in the abstract.", "study_duration": "16 weeks of treatment, with follow-up up to 77 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:08.919668+00:00"}
{"study_id": 186406, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a combination of dietary supplements, including curcumin, could improve cardiovascular and metabolic health in non-obese individuals.", "results_summary": "The study found that 900 mg of curcumin, taken daily as part of a 10-supplement regimen, did not improve arterial stiffness, endothelial function, or any measured cardiometabolic risk factors. No significant effects on inflammation, oxidative stress, or other biomarkers were observed.", "population_specificity": "Non-obese men and women (BMI 21.0-29.9 kg/m\u00b2), aged 38-55 years.", "effective_dosage": "900 mg daily (as part of a multi-supplement regimen).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:09.971419+00:00"}
{"study_id": 186407, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of bioavailability-boosted curcuminoids as adjuvant therapy in improving quality of life and reducing systemic inflammation in cancer patients undergoing standard chemotherapy.", "results_summary": "Curcuminoid supplementation significantly improved quality of life and reduced systemic inflammation markers (TNF-\u03b1, TGF\u03b2, hs-CRP, CGRP, MCP-1, substance P) compared to placebo, though IL-8 reduction was greater with placebo. Quality of life improvements correlated with reductions in TGF\u03b2 levels.", "population_specificity": "80 subjects with solid tumors under standard chemotherapy regimens.", "effective_dosage": "180 mg/day of bioavailability-boosted curcuminoids.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:10.037688+00:00"}
{"study_id": 186410, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate Curcumin as a chemopreventive agent targeting the NF-\u03baB pathway in head and neck squamous cell carcinoma (HNSCC).", "results_summary": "The abstract suggests Curcumin is appealing due to its safety profile and potential to inhibit the NF-\u03baB pathway, though specific efficacy data in HNSCC is not detailed.", "population_specificity": "Head and neck squamous cell carcinoma (HNSCC) patients or at-risk individuals.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:10.416940+00:00"}
{"study_id": 186409, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of nutraceuticals, including curcumin, in preventing and treating prostate cancer by modulating key signaling pathways and cancer stem cell-related mechanisms.", "results_summary": "The study found that curcumin, among other nutraceuticals, can downregulate critical signal transduction pathways (AR, Akt, NF-\u03baB) involved in prostate cancer progression and may inhibit prostatic cancer stem cells, potentially improving treatment outcomes when combined with conventional therapies.", "population_specificity": "Men with prostate cancer, particularly focusing on androgen-sensitive to castrate-resistant progression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:10.433457+00:00"}
{"study_id": 186411, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether curcumin supplementation could mitigate exercise-induced oxidative stress in humans by enhancing antioxidant capacity.", "results_summary": "Curcumin supplementation (both single and double doses) significantly reduced exercise-induced oxidative stress markers and increased antioxidant potential compared to placebo, indicating its effectiveness in attenuating oxidative stress.", "population_specificity": "10 male participants, ages 26.8\u00b12.0 years.", "effective_dosage": "90 mg of curcumin, administered 2 hours before exercise and immediately after exercise in the double supplementation trial.", "study_duration": "Single exercise session (60 minutes) with blood sampling pre-exercise, immediately post-exercise, and 2 hours post-exercise.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:13.744965+00:00"}
{"study_id": 186413, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy of nutritional supplements, including curcumin, in promoting diabetic wound healing based on human and animal studies.", "results_summary": "The study found that curcumin showed notable effectiveness in promoting wound healing in animal studies, but human studies did not demonstrate significant positive outcomes. More human research is needed to confirm efficacy.", "population_specificity": "Diabetic patients with foot ulcers (human studies) and diabetic animal models (animal studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:16.738349+00:00"}
{"study_id": 186412, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to systematically review and meta-analyze clinical evidence on the effects of curcumin supplementation on blood lipids, including total cholesterol, LDL-C, HDL-C, and triglycerides.", "results_summary": "The meta-analysis found no significant effect of curcumin on any lipid parameters, with pooled mean changes for total cholesterol, LDL-C, HDL-C, and triglycerides all showing non-significant results. Subgroup analysis in patients at cardiovascular risk also showed no significant impact on lipid levels.", "population_specificity": "Heterogeneous populations, including patients at cardiovascular risk.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:16.992572+00:00"}
{"study_id": 186416, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to review the pharmaceutical uses of curcumin for various diseases, evaluating its safety, efficacy, and molecular mechanisms.", "results_summary": "The study found that curcumin modulates multiple signaling pathways and has potential therapeutic benefits for cancer, pulmonary, neurological, liver, metabolic, autoimmune, and cardiovascular diseases. Clinical trials and preclinical studies support its safety and efficacy in humans and animals.", "population_specificity": "Humans and animals (rodents, monkeys, horses, rabbits, cats).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:17.899146+00:00"}
{"study_id": 186414, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether curcuminoid supplementation reduces circulating CRP levels, a marker of inflammation linked to cardiovascular disease.", "results_summary": "The meta-analysis found that curcuminoid supplementation significantly reduced CRP levels compared to placebo, particularly with bioavailability-improved preparations and durations of \u22654 weeks. The effect was statistically significant but varied by preparation type and supplementation duration.", "population_specificity": "172 subjects in the curcuminoid group and 170 in the placebo group across six clinical trials (specific demographics not detailed).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Subgroup analysis highlighted effectiveness with durations of \u22654 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:17.971111+00:00"}
{"study_id": 186415, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of curcuminoid supplementation on oxidative stress (measured by serum PAB) and antibody titres (anti-Hsp27 and anti-oxLDL) in obese individuals.", "results_summary": "Curcuminoid supplementation significantly reduced oxidative stress (PAB) but did not significantly affect anti-Hsp27 or anti-oxLDL levels. The findings suggest curcuminoids may help reduce oxidative stress, though larger studies are needed for validation.", "population_specificity": "30 obese individuals", "effective_dosage": "1 g/day", "study_duration": "30 days per intervention period (with a 2-week washout)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:18.446404+00:00"}
{"study_id": 186418, "supplement_id": 1062, "safety_score": "95", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of standard BPH treatment with or without curcumin (Meriva\u00ae) as an adjuvant in reducing symptoms and improving quality of life.", "results_summary": "The study found that adding Meriva\u00ae to standard treatment significantly improved IPSS scores, quality of life, and reduced urinary infections and block episodes compared to standard treatment alone, with no reported side effects.", "population_specificity": "Symptomatic BPH patients aged 55-65 with no other clinical or metabolic issues.", "effective_dosage": "2 tablets/day (2 x 500 mg Meriva\u00ae, equivalent to 2 x 100 mg curcumin/day).", "study_duration": "At least 24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:20.136616+00:00"}
{"study_id": 186419, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether curcumin supplementation could reduce inflammation and improve pruritus severity and quality of life in patients with chronic sulphur mustard-induced skin lesions.", "results_summary": "Curcumin significantly reduced serum IL-8, hs-CRP, and CGRP levels compared to placebo, with correlations between inflammatory biomarker changes and quality of life improvements. No significant change was observed in IL-6 levels.", "population_specificity": "96 male Iranian veterans (aged 37-59) with chronic sulphur mustard-induced pruritic skin lesions.", "effective_dosage": "1 g/d", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:22.377668+00:00"}
{"study_id": 186421, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether curcuminoid supplementation (1 g/day) could improve lipid profiles and anthropometric parameters in obese individuals.", "results_summary": "Curcumin supplementation significantly reduced serum triglycerides but did not affect other lipid profile parameters, body mass index, or body fat. No significant changes were observed in high-sensitivity C-reactive protein levels.", "population_specificity": "Obese individuals (n=30)", "effective_dosage": "1 g/day", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:24.482671+00:00"}
{"study_id": 186420, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review nanotechnology-based delivery approaches to improve the bioavailability and biological activity of Curcumin.", "results_summary": "The study highlights Curcumin's potential pharmacological benefits in inflammatory disorders, cardiovascular disease, cancer, and neurological disorders but notes its limitations due to poor bioavailability and rapid metabolism. Nanotechnology-based delivery systems, such as liposomes and polymeric nanoparticles, show promise in enhancing Curcumin's effectiveness.", "population_specificity": "Not specified (general review, not a clinical study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:24.972774+00:00"}
{"study_id": 186422, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the biological activities of curcumin, focusing on its molecular, cellular, and clinical effects, as well as its potential therapeutic applications.", "results_summary": "Curcumin modulates multiple signaling molecules and exhibits diverse biological activities, including anti-inflammatory, antioxidant, and chemopreventive properties. Animal studies suggest efficacy against various human diseases, but clinical approval for treatment remains lacking.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:26.175374+00:00"}
{"study_id": 186423, "supplement_id": 1062, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether curcumin could effectively alleviate sulphur mustard-induced chronic pruritus and improve quality of life in affected individuals.", "results_summary": "Curcumin significantly reduced serum substance P levels, antioxidant enzyme activities, and pruritus severity measures (pruritus score, VAS, SCORAD, and DLQI) compared to placebo. It also showed a greater improvement in quality of life than the placebo group.", "population_specificity": "96 male Iranian veterans (aged 37-59 years) with sulphur mustard-induced chronic pruritus.", "effective_dosage": "1 g/d", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:26.673579+00:00"}
{"study_id": 186424, "supplement_id": 1062, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the effects of different doses of curcumin (500 mg/day and 6 g/day) versus vitamin E (200 IU/day) on plasma antioxidant capacity and serum cholesterol levels over 7 days.", "results_summary": "Curcumin at 500 mg/day significantly increased plasma antioxidant capacity and reduced serum cholesterol and triglyceride levels, while 6 g/day showed a smaller antioxidant effect. Vitamin E increased antioxidant capacity but had minimal impact on cholesterol or triglycerides.", "population_specificity": "Not specified (abstract does not detail participant demographics).", "effective_dosage": "500 mg/day and 6 g/day of curcumin; 200 IU/day of vitamin E.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:28.887878+00:00"}
{"study_id": 186417, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of curcumin and its metabolite THC on lifespan extension and oxidative stress responses in model organisms.", "results_summary": "Curcumin and THC increased mean lifespan in nematodes, fruit flies, and mice by reducing oxidative stress and regulating age-related genes. The effects were linked to upregulation of SOD activity and downregulation of specific aging-related genes.", "population_specificity": "Model organisms (nematode roundworm, fruit fly Drosophila, and mouse).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:29.170311+00:00"}
{"study_id": 186425, "supplement_id": 1062, "safety_score": "90", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of oral curcumin supplementation on proteinuria, hematuria, and systolic blood pressure in patients with relapsing or refractory lupus nephritis.", "results_summary": "Curcumin supplementation significantly reduced proteinuria, hematuria, and systolic blood pressure in patients with lupus nephritis, with no adverse effects reported. Placebo capsules showed no significant effects on measured variables.", "population_specificity": "24 patients with relapsing or refractory biopsy-proven lupus nephritis.", "effective_dosage": "500 mg turmeric (22.1 mg curcumin) per capsule, 3 capsules daily (one with each meal).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:29.180726+00:00"}
{"study_id": 186426, "supplement_id": 1062, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether turmeric (containing curcumin) could reduce serum and urinary TGF-\u03b2, IL-8, TNF-\u03b1, and proteinuria in patients with overt type 2 diabetic nephropathy.", "results_summary": "Turmeric supplementation significantly reduced serum TGF-\u03b2 and IL-8, urinary protein excretion, and IL-8 levels, with no reported adverse effects.", "population_specificity": "40 patients with overt type 2 diabetic nephropathy (20 in trial group, 20 in control group).", "effective_dosage": "500 mg turmeric per capsule (22.1 mg curcumin), three capsules daily (one with each meal).", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:31.266046+00:00"}
{"study_id": 186427, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether curcumin, in combination with soy isoflavones, could modulate serum PSA levels and suppress PSA production in prostate cells through anti-androgen effects.", "results_summary": "The study found that combined treatment with isoflavones and curcumin significantly decreased PSA production in LNCaP cells and suppressed androgen receptor expression. In clinical trials, PSA levels decreased in patients with baseline PSA \u226510 \u00b5g/ml who took the supplement (P = 0.01).", "population_specificity": "Men who received prostate biopsies but were not diagnosed with prostate cancer.", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:33.295580+00:00"}
{"study_id": 186428, "supplement_id": 1062, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to determine whether curcumin, as a selective COX2 inhibitor, could reduce PGE\u2082 release and A\u03b2\u2084\u2082 secretion in human amyloid-\u03b2 protein precursor-transfected CHO cells.", "results_summary": "Curcumin significantly inhibited PGE\u2082 release but did not reduce A\u03b2\u2084\u2082 secretion; instead, it increased A\u03b2\u2084\u2082 production in this cell system. Its effects on PGE\u2082 were comparable to Celebrex, another COX2 inhibitor.", "population_specificity": "Human amyloid-\u03b2 protein precursor-transfected Chinese Hamster Ovary (CHO) cells.", "effective_dosage": "Not specified", "study_duration": "24-hour incubation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:33.706431+00:00"}
{"study_id": 11360, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether cyanidin-3-O-glucoside (C3G) could inhibit epithelial-to-mesenchymal transition (EMT) and extracellular matrix (ECM) deposition in renal fibrosis via the NDRG2 and PI3K/AKT pathways.", "results_summary": "C3G inhibited EMT and ECM deposition in renal fibrosis models, reversed NDRG2 downregulation, and suppressed PI3K/AKT pathway activation. Combined C3G and si-NDRG2 treatment enhanced these effects compared to C3G alone.", "population_specificity": "In vivo (unilateral ureteral obstruction model) and in vitro (TGF-\u03b21-induced HK-2 cells) models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:35.935990+00:00"}
{"study_id": 11361, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the biosynthesis of cyanidin-3-glucoside-4-vinylcatechol (C3G_VC) and its potential to mitigate cadmium (Cd)-induced liver damage, oxidative stress, and gut microbiome inflammation in mice.", "results_summary": "C3G_VC intervention in Cd-exposed mice significantly reduced oxidative stress and liver injury by lowering malondialdehyde (MDA) levels, increasing antioxidant enzyme activity (SOD, GSH-PX), and regulating bile acid (BA) metabolism. It also modulated gut microbiota by increasing the abundance of beneficial bacteria like Faecalibaculum and Akkermansia.", "population_specificity": "Cd-exposed mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:36.982753+00:00"}
{"study_id": 11364, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of cyanidin and C3G in alleviating peptic ulcer disease (PUD) by examining their mechanisms of action and therapeutic efficacy in preclinical studies.", "results_summary": "Cyanidin and C3G were found to alleviate PUD by inhibiting pro-inflammatory cytokines, reducing gastric mucosa inflammation, and decreasing lipid peroxidation. However, clinical validation is needed to confirm their therapeutic potential in humans.", "population_specificity": "Preclinical studies (in vitro and in vivo models)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:37.328743+00:00"}
{"study_id": 11362, "supplement_id": 1063, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to investigate the underlying mechanisms of Cyanidin-3-O-glucoside (Cy3g) in inhibiting colorectal cancer (CRC) progression, focusing on its effects on cell viability, proliferation, migration, invasion, and apoptosis.", "results_summary": "Cy3g significantly inhibited CRC cell viability, proliferation, migration, and invasion while promoting apoptosis. It upregulated KLF4 expression and inactivated the ERK/p38 pathway, with these effects validated in a xenograft mouse model.", "population_specificity": "Human colorectal cancer cell lines (SW620, HT29, LS174T, HCT116) and normal colon fibroblast cell line (CCD-18Co), as well as a xenograft mouse model.", "effective_dosage": "Not specified (dose-dependent effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:38.901518+00:00"}
{"study_id": 11363, "supplement_id": 1063, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the immunomodulatory potential of cyanidin-3-glucoside (C3G) on mesenchymal stem cells (MSCs) and its subsequent effects on macrophage and lymphocyte responses.", "results_summary": "C3G at 50 \u00b5M was non-toxic to MSCs and reduced IL-1\u03b2 production in LPS-stimulated MSCs. Conditioned media from C3G-treated MSCs modulated immune cell responses more effectively than C3G alone, decreasing pro-inflammatory cytokines (TNF-\u03b1, IL-1\u03b2, IL-6, IL-12, IL-2) and increasing anti-inflammatory IL-10.", "population_specificity": "Mesenchymal stem cells (MSCs), macrophages, and lymphocytes in vitro.", "effective_dosage": "50 \u00b5M C3G", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:39.154385+00:00"}
{"study_id": 11365, "supplement_id": 1063, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of Cyanidin-3-glucoside (C3G) on inflammatory mechanisms and migration properties of leukemic cells.", "results_summary": "C3G doses up to 50 \u00b5M did not affect cell metabolism, viability, or cell cycle phases but significantly reduced TNF-\u03b1, IL-8, CCL2 production, p-NF\u03baB/NF\u03baB ratio, and migration rates in LPS- or fMLP-challenged leukemic cells.", "population_specificity": "Leukemic cells (in vitro study).", "effective_dosage": "Up to 50 \u00b5M.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:40.339572+00:00"}
{"study_id": 11366, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the chemoprotective efficacy of Cyanidin-3-glucoside (C3G) in a rat model of colorectal cancer induced by 1,2-dimethylhydrazine (DMH).", "results_summary": "C3G significantly reduced tumor incidence and weight, restored body weight, and modulated biochemical markers, inflammatory mediators, and apoptotic pathways, demonstrating potent chemopreventive effects against colorectal cancer.", "population_specificity": "DMH-induced colorectal cancer rat model.", "effective_dosage": "10 and 15 mg/kg.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:41.675323+00:00"}
{"study_id": 11367, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Cyanidin-3-O-glucoside (C3G) could mitigate the intergenerational reproductive impairments in offspring caused by paternal high-fructose and high-fat diet (HFHFD).", "results_summary": "Paternal HFHFD did not cause observable reproductive impairments in the fathers but negatively affected offspring testicular function and sperm counts when exposed to a high-fat diet. C3G intervention significantly mitigated these adverse effects in offspring.", "population_specificity": "Male mice and their offspring.", "effective_dosage": "Not specified.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:43.039550+00:00"}
{"study_id": 11369, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the role and mechanism of Cyanidin-3-O-glucoside (C3G) in regulating cholesterol anabolism under oxidative stress in HEK-293T cells.", "results_summary": "C3G reduced oxidative stress by inhibiting the SREBP2/HMGCR pathway, lowering cholesterol levels, increasing ATP, and reducing acetyl-CoA. It also reversed ROS accumulation and mitochondrial membrane potential decline caused by HMGCR.", "population_specificity": "HEK-293T cells (human embryonic kidney cells)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:44.991196+00:00"}
{"study_id": 11368, "supplement_id": 1063, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to identify potential CNT2 inhibitors, specifically evaluating cyanidin-3-O-galactoside (Cy3Gal), for treating hyperuricemia by reducing serum and urine uric acid levels.", "results_summary": "Cy3Gal demonstrated potent CNT2 inhibition (IC50 = 9.40 \u03bcM), effectively reduced uric acid and adenosine levels in vivo (5-20 mg/kg), and showed minimal cytotoxicity or renal toxicity compared to standard treatments.", "population_specificity": "In vitro (mTEC and hIEC cells) and in vivo (animal model, species not specified).", "effective_dosage": "5-20 mg/kg in vivo; 100 \u03bcM in cytotoxicity assays.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:45.909400+00:00"}
{"study_id": 11372, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects and mechanisms of Cyanidin-3-O-glucoside (C3G) on ethanol-induced liver injury in a mouse model of alcohol-associated liver disease (ALD).", "results_summary": "C3G administration reduced ethanol-induced liver injury by suppressing oxidative stress, hepatic lipid accumulation, and inflammation. It activated the AMPK pathway and enhanced mitophagy to eliminate damaged mitochondria, reducing reactive oxidative species in hepatocytes.", "population_specificity": "Gao-binge mouse model of ALD and AML12 hepatocytes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:47.464068+00:00"}
{"study_id": 11370, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to discover the molecular mechanisms by which cyanidin-3-O-glucoside (C3G) ameliorates ulcerative colitis (UC)-induced male reproductive disorders.", "results_summary": "C3G effectively reduced pro-inflammatory cytokine IL-6 in the testis via the cytokine-cytokine receptor interaction pathway and restored mRNA expression levels of Ly6a and Col1a1, which are linked to UC-induced reproductive damage. The study suggests C3G may be a promising dietary supplement for improving male reproductive health in UC patients.", "population_specificity": "Male mice with DSS-induced colitis (a model for UC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:47.927050+00:00"}
{"study_id": 11373, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to investigate the neuroprotective properties of cyanidin against BPA-induced Alzheimer's-like neuropathology in an in vivo model.", "results_summary": "Cyanidin significantly improved memory, reduced p-tau and GSK3\u03b2 levels, restored Wnt3 and \u03b2-catenin levels, and exhibited antioxidant properties by elevating catalase and superoxide dismutase. It also reduced acetylcholinesterase concentrations in the cortex and hippocampus.", "population_specificity": "Three-week-old Sprague-Dawley rats", "effective_dosage": "5 mg/kg and 10 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:49.060447+00:00"}
{"study_id": 11374, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate how cyanidin-3-O-glucoside (C3G) modulates gut bacteria and their metabolites to alleviate colonic inflammation induced by microplastic polystyrene (PS) exposure.", "results_summary": "C3G effectively reversed PS-induced pro-inflammatory cytokine levels and mRNA expression, inhibited reductions in anti-inflammatory cytokines, and restored gut bacterial composition. It also enhanced bacterial genes involved in tryptophan and bile acid metabolism pathways, leading to upregulated beneficial metabolites.", "population_specificity": "C57BL/6 mouse model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:51.439157+00:00"}
{"study_id": 11376, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether cyanidin-3-O-glucoside (C3G) could alleviate insulin resistance (IR) and improve glucose metabolism in hepatocytes and diabetic mice.", "results_summary": "C3G improved insulin sensitivity by enhancing glucose consumption and glycogen synthesis in IR hepatocytes, suppressed PTP1B expression, and increased IRS-2 phosphorylation. These effects were confirmed in diabetic db/db mice, suggesting C3G's potential to regulate glucose metabolism in T2DM.", "population_specificity": "HepG2 and L02 cells, C57BL/6J male mice, and db/db male mice.", "effective_dosage": "150 mg/kg/day (oral gavage in mice).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:54.514803+00:00"}
{"study_id": 11377, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of cyanidin on immune system modulation, intestinal flora, and glucose homeostasis in rats with type-2 diabetes.", "results_summary": "Cyanidin administration significantly improved glucose tolerance, reduced serum cholesterol and LDL levels, increased HDL/LDL ratio, and positively altered gut microbiota composition in diabetic rats.", "population_specificity": "Rats with type-2 diabetes", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:54.805148+00:00"}
{"study_id": 11371, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect and mechanism of Cyanidin-3-O-glucoside (C3G) on LPS-induced endometritis in mice.", "results_summary": "C3G significantly reduced uterine inflammation, improved pathological injury, and inhibited MPO activity. It suppressed the NF\u03baB pathway and pro-inflammatory cytokines while promoting the PPAR\u03b3/ABCA1 pathway, with its anti-inflammatory effects weakened by a PPAR\u03b3 inhibitor.", "population_specificity": "Mice with LPS-induced endometritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:56.777661+00:00"}
{"study_id": 10726, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of DHA-concentrated fish oil supplementation on the cognitive function of puppies.", "results_summary": "The study found that puppies supplemented with DHA showed improved cognitive function in object discrimination tests and higher serum EPA + DHA concentrations, without increased lipid oxidation. No significant changes in total antioxidant capacity were observed between groups.", "population_specificity": "3-month-old puppies, blocked by breed", "effective_dosage": "40 mg DHA/kg body weight/day", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:51.585421+00:00"}
{"study_id": 10725, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if DHA reduces LPS-induced inflammatory hyperalgesia by modulating the TRAF6/IKK/IkB-a/NF-\u03baB signaling pathway in the central nervous system.", "results_summary": "DHA significantly improved thermal stimulus latency in LPS-injected mice and prevented increased expression/activity of key inflammatory pathway components in the brain and spinal cord. These findings suggest DHA's protective effect against inflammatory hyperalgesia via NLRX1-TRAF6 dissociation.", "population_specificity": "Male mice", "effective_dosage": "Not specified", "study_duration": "6 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:52.089274+00:00"}
{"study_id": 10731, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether docosahexaenoic acid (DHA) supplementation could reduce seizure susceptibility and microglial activation following complex febrile seizures in infancy.", "results_summary": "DHA supplementation after febrile seizures suppressed increased seizure susceptibility and attenuated microglial activation in mice, suggesting potential protective effects against post-growth seizures. The study found that DHA clearly reduced seizure sensitivity and abnormal electroencephalogram patterns associated with complex febrile seizures.", "population_specificity": "Infant mice (10 days old) with induced febrile seizures.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:52.371345+00:00"}
{"study_id": 10723, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining MCTs with DHA could improve brain glucose metabolism and reduce AD-related protein expression in APP/PS1 mice.", "results_summary": "The study found that MCTs combined with DHA improved brain glucose metabolism, reduced nerve cell apoptosis, and decreased the expression of AD-related proteins (A\u03b2, APP, BACE1, PS1) more effectively than either supplement alone.", "population_specificity": "APP/PS1 mice (a model for Alzheimer's disease).", "effective_dosage": "Not specified.", "study_duration": "8 months (from age 3 to 11 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:52.617904+00:00"}
{"study_id": 10730, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether EPA/DHA supplementation could improve high-risk coronary plaque features in CAD patients under statin therapy.", "results_summary": "The study found that EPA/DHA therapy at 2 or 4 g/day did not significantly improve high-risk coronary plaque features as evaluated by CMR or CTA. No significant differences in plaque changes were observed among the treatment groups.", "population_specificity": "CAD patients with low-density lipoprotein cholesterol levels <100 mg/dL (mean age: 68.2 years, 85% male).", "effective_dosage": "2 g/day and 4 g/day EPA/DHA.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:52.695991+00:00"}
{"study_id": 10727, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of nanocapsules containing DHA (MLNC-DHA-a1) on biomarkers of chronic inflammation in vitro and in vivo.", "results_summary": "MLNC-DHA-a1 nanocapsules reduced TNF\u03b1 and promoted M2 macrophage polarization in vitro but increased systemic pro-inflammatory cytokines (IL-6, IL-1\u03b2, IL-10) in vivo. The intervention was well-tolerated but raised concerns about immune response.", "population_specificity": "LDLr(-,-) mice fed a Western diet to induce chronic inflammation.", "effective_dosage": "Intravenous injection via the caudal vein once a week.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:52.842721+00:00"}
{"study_id": 10728, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the individual and combined effects of docosahexaenoic acid (DHA) and calcitriol on ovarian cancer cell growth, VDR abundance, and markers of cell cycle progression and apoptosis.", "results_summary": "DHA alone inhibited OVCAR4 ovarian cancer cell growth, and its combination with calcitriol enhanced this inhibitory effect. Long-term treatment (12 days) showed stronger growth inhibition at lower concentrations compared to short-term treatment (3 days), accompanied by decreased c-Myc and increased p27 levels.", "population_specificity": "OVCAR4 ovarian cancer cells (in vitro study).", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 days (short-term) and 12 days (long-term).", "interactions": "Enhanced inhibitory effect when combined with calcitriol.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:53.757667+00:00"}
{"study_id": 10729, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to optimize the biotransformation of DHA-enriched oil hydrolysate into Resolvin D5 (RvD5) using a bioreactor for large-scale production of specialized pro-resolving mediators (SPMs).", "results_summary": "The study successfully optimized the conversion of DHA into RvD5, achieving a 15-fold increase in yield (4.0 mM RvD5 from 5.0 mM DHA) with >97% purity, demonstrating an efficient method for SPM production.", "population_specificity": "Not specified (in vitro study using Escherichia coli and human macrophage-derived processes).", "effective_dosage": "5.0 mM (1.64 g/L) DHA in oil hydrolysate.", "study_duration": "3.0 hours (bioreactor reaction time).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:53.897690+00:00"}
{"study_id": 10733, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effects of high-dose DHA supplementation as add-on therapy for reducing seizure frequency in dogs with idiopathic epilepsy.", "results_summary": "Four of six dogs showed a \u226550% reduction in seizure frequency within 2-3 months, with three achieving 0-1 seizures per month after 5-6 months. No adverse events were observed.", "population_specificity": "Six dogs (median age: 6 years) diagnosed with idiopathic epilepsy.", "effective_dosage": "69-166 mg/kg/day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:00.372632+00:00"}
{"study_id": 10732, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of docosahexaenoic acid (DHA) plus piracetam versus piracetam alone in reducing the frequency and severity of breath-holding spells (BHS) in infants and preschool children.", "results_summary": "The study found that DHA plus piracetam significantly reduced the occurrence of BHS to 16% after six months, compared to 50% with piracetam alone (P = 0.001), indicating superior efficacy of the combined treatment.", "population_specificity": "Infants and preschool children diagnosed with breath-holding spells.", "effective_dosage": "Not specified", "study_duration": "Six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:00.440209+00:00"}
{"study_id": 10734, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop and evaluate injectable Lactotransferrin-loaded dextran nanoparticles coated with docosahexaenoic acid (LLDDNP) for physicochemical properties, biomarker modulation, and immune response.", "results_summary": "LLDDNP demonstrated thermal stability, crystalline nature, and predictable in vitro release kinetics. In vivo, it significantly modulated cytokine levels and liver biomarkers, showing high efficacy in treatment groups (p < 0.001).", "population_specificity": "Not specified (in vivo study, likely animal model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:00.815104+00:00"}
{"study_id": 10737, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the role of DHA in modulating cellular antioxidant enzymes and explore its potential molecular mechanisms, including Nrf2 activation.", "results_summary": "The review found that DHA may help regulate cellular antioxidant defenses through Nrf2 activation, though results varied due to differences in experimental conditions such as dosage, duration, and model systems.", "population_specificity": "Cell cultures and animal models (no specific human population mentioned).", "effective_dosage": "Not specified (varied across studies).", "study_duration": "Not specified (varied across studies).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:00.865748+00:00"}
{"study_id": 10736, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a structured triglyceride form of DHA (DHA-TG) improves healthspan, specifically motility and antioxidant capacity, in aged C. elegans.", "results_summary": "DHA-TG improved motility at all measured ages and enhanced antioxidant capacity by increasing SOD activity and expression in aged C. elegans, with effects dependent on the DAF-16/FOXO pathway.", "population_specificity": "Aged C. elegans (nematodes)", "effective_dosage": "Not specified", "study_duration": "Monitored at 4, 8, and 12 days of adulthood", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:02.360662+00:00"}
{"study_id": 10735, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of docosahexaenoic acid (DHA) liposomes synthesized via a microfluidic system for glioblastoma (GBM) therapy.", "results_summary": "DHA liposomes were successfully internalized by GBM cells, reduced cell viability, and triggered apoptotic pathways more efficiently than free DHA through caspase-3-dependent mechanisms. The study demonstrated the potential of DHA liposomes as a nanomedicine platform for cancer therapy.", "population_specificity": "Glioblastoma (GBM) cells in vitro.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:02.934877+00:00"}
{"study_id": 10739, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if docosahexaenoic acid (DHA) could alleviate symptoms of rheumatoid arthritis (RA), including pain, dysmobility, sarcopenia, and metabolic alterations, either alone or in combination with an anti-TNF therapy (Etanercept).", "results_summary": "DHA reduced the impact of RA on body composition and metabolic alterations but showed no synergistic effects with Etanercept. While Etanercept was more effective for pain and RA scoring, DHA demonstrated benefits as a preventive nutritional intervention for patients not requiring pharmacological therapy.", "population_specificity": "Rats with collagen-induced arthritis (CIA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:03.534800+00:00"}
{"study_id": 10738, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of high-concentration DHA supplementation on fatty acid profiles in pediatric cystic fibrosis patients and assess its safety and efficacy in correcting AA/DHA imbalance.", "results_summary": "The study found that DHA supplementation significantly increased n-3 PUFAs (DHA and EPA) and decreased n-6 PUFAs (arachidonic acid) in erythrocyte membranes, with effects observed at 6 months and further at 12 months. The treatment was safe and well-tolerated but did not fully normalize essential fatty acid alterations.", "population_specificity": "Pediatric patients with cystic fibrosis (mean age 11.7 years).", "effective_dosage": "50 mg/kg/day of Tridocosahexanoin-AOX\u00ae 70%.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:03.859276+00:00"}
{"study_id": 10741, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the therapeutic effect and mechanism of DHA in reducing cadmium (Cd) poisoning in mice, focusing on gut microbiota modulation.", "results_summary": "DHA increased fecal Cd excretion and reduced Cd accumulation in organs, restored Parabacteroides abundance, and P. distasonis (a gut bacterium) played a key role in Cd excretion via succinic acid production.", "population_specificity": "Cd-exposed mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:08.157721+00:00"}
{"study_id": 10740, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the influence of Docosahexaenoic Acid (DHA) on neuronal nitric oxide synthase (nNOS) and Ca2+/calmodulin-dependent protein kinase II (CaMKII) protein expression in differentiated NG108-15 cells.", "results_summary": "DHA tended to enhance nNOS protein expression on days 5 and 6 compared to day 0, and significantly increased CaMKII protein expression on day 6. No significant morphological differences were observed between cells with or without DHA treatment.", "population_specificity": "Differentiated NG108-15 cells (a neuronal cell line).", "effective_dosage": "Not specified.", "study_duration": "6 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:09.414052+00:00"}
{"study_id": 10743, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of docosahexaenoic acid (DHA) delivered via a targeted nanogel system (Apt-NG) in promoting the browning of white adipocytes as a potential obesity treatment.", "results_summary": "DHA@Apt-NG treatment led to morphological changes in lipid droplets, reduced triglyceride levels, increased mitochondrial activity, and up-regulated mRNA expression of key browning-related genes (Ucp1, Pgc-1\u03b1, Pparg, and Prdm16). The study demonstrated effective browning of white adipocytes using the targeted delivery system.", "population_specificity": "White adipocytes (in vitro or animal model, not specified in abstract).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:10.739613+00:00"}
{"study_id": 10744, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the metabolism, trafficking, and function of DHA and VLC-PUFAs in the retina, including their potential role in retinal diseases.", "results_summary": "The study highlights DHA's abundance in photoreceptor outer segments and its role as a precursor for bioactive lipids. It discusses pathological features from PUFA-deficient models and evaluates DHA's potential involvement in retinal degeneration diseases like diabetic retinopathy and age-related macular degeneration.", "population_specificity": "Mouse models and corresponding patients with enzyme or transporter defects, as well as broader implications for retinal diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:10.877391+00:00"}
{"study_id": 10746, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the radiosensitivity changes caused by DHA on esophageal cancer cells and explore its potential as an adjuvant therapy before radiotherapy.", "results_summary": "DHA improved radiosensitivity in TE-1 and TE-10 esophageal cancer cells in vitro and in vivo, with increased PPAR-\u03b3 expression contributing to the effect. Inhibiting PPAR-\u03b3 attenuated the benefits of DHA.", "population_specificity": "Esophageal cancer cells (TE-1 and TE-10) and mouse transplanted tumor models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Cooperates with radiation therapy; potential interaction with PPAR-\u03b3 inhibitors.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:11.988135+00:00"}
{"study_id": 10742, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effect of high-dose omega-3 fatty acids, including docosahexaenoic acid (DHA), on metabolic and inflammatory markers in obese patients and healthy volunteers.", "results_summary": "Supplementation improved metabolic markers (insulin, HOMA-IR, TG/HDL ratio, TG, AA/EPA ratio) and reduced inflammatory markers (TNF-\u03b1, mRNA transcripts of T CD4+ subsets). Effects on metabolism were short-lived, while inflammatory modulation persisted longer after discontinuation.", "population_specificity": "12 women with obesity (BMI \u2265 35.0 kg/m\u00b2) and 12 healthy women (BMI < 24.0 kg/m\u00b2).", "effective_dosage": "4.8 g/day (1.6 g DHA + 3.2 g EPA).", "study_duration": "3 months of supplementation, followed by 1 month without treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:12.162473+00:00"}
{"study_id": 10748, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether docosahexaenoic acid (DHA) could mitigate lipopolysaccharide (LPS)-induced placental inflammation and fetal growth restriction (FGR) by activating PPAR\u03b3 and promoting p65 ubiquitination and degradation.", "results_summary": "DHA pretreatment reduced LPS-induced FGR incidence, attenuated pro-inflammatory cytokine expression (Tnf-\u03b1, Il-6, Il-1\u03b2, Mip-2, Kc), increased anti-inflammatory IL-10 levels, and inhibited NF-\u03baB signaling via PPAR\u03b3-dependent p65 ubiquitination and degradation.", "population_specificity": "Pregnant CD-1 mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:12.746684+00:00"}
{"study_id": 10747, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine if propionate wastewater could be effectively used as a substrate and water source for Schizochytrium sp. to enhance DHA and lipid production through genetic engineering and fermentation optimization.", "results_summary": "The study found that overexpression of methylmalonyl-CoA mutase (MCM) in Schizochytrium sp. significantly improved propionate metabolism, enabling the engineered strain to completely replace clean water with propionate wastewater (5 g L-1). This resulted in a 26.8% increase in biomass and a 51.7% increase in lipid yield compared to the wild type, with enhanced DHA synthesis driven by ATP production and improved antioxidant capacity.", "population_specificity": "Schizochytrium sp. (oleaginous microorganism)", "effective_dosage": "5 g L-1 propionate in wastewater", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:14.647585+00:00"}
{"study_id": 10749, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the role of endoplasmic reticulum (ER) stress in DHA-induced apoptosis in grass carp adipocytes and identify potential mechanisms involving BOK genes.", "results_summary": "DHA induced adipocyte apoptosis via ER stress, upregulating BOKa and BOKb expression, which was suppressed by the ER stress inhibitor 4-PBA. The study identified IRE1\u03b1 and ATF6 signaling pathways as key mediators in this process.", "population_specificity": "Grass carp (Ctenopharyngodon idellus) adipocytes (in vivo and in vitro)", "effective_dosage": "200 \u03bcM DHA (in vitro)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:17.647648+00:00"}
{"study_id": 10750, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether DHA co-treatment could enhance doxorubicin's ability to inhibit growth and invasion in drug-resistant MCF-7 breast cancer cells.", "results_summary": "The DHA-doxorubicin combination effectively increased cancer cell death, reduced invasive ability, enhanced doxorubicin accumulation, triggered apoptosis, and decreased P-gp and TG2 levels. It also increased pro-apoptotic molecules and lipid peroxidation.", "population_specificity": "MCF-7/Dox breast cancer cells (drug-resistant in vitro model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:17.935783+00:00"}
{"study_id": 10752, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the EPA/DHA lipid composition of fish oil processed through different methods and assess its bioavailability.", "results_summary": "Enzymatic treatment increased EPA/DHA incorporation as diacylglycerol, while silica gel column chromatography enriched EPA/DHA as phosphatidylglycerol and phosphatidylethanolamine. Higher purity EPA/DHA improved bioavailability, with triglyceride forms outperforming ethyl ester forms.", "population_specificity": "Caco-2 cell monolayer model (in vitro study)", "effective_dosage": "Not specified", "study_duration": "24-hour incubation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:19.088991+00:00"}
{"study_id": 10754, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of 17-oxo-DHA, a metabolite of DHA, on UVB-induced oxidative stress, inflammation, and carcinogenesis in mouse skin.", "results_summary": "Topical 17-oxo-DHA reduced UVB-induced cell death, oxidative stress markers, and inflammation by inhibiting STAT3 phosphorylation and activating Nrf2. It also enhanced macrophage efferocytosis and reduced skin carcinogenesis and tumor angiogenesis.", "population_specificity": "Hairless mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:20.294502+00:00"}
{"study_id": 10751, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to assess whether DHA supplementation in women with gestational diabetes mellitus (GDM) affects neonatal metabolic health biomarkers, particularly leptin and adiponectin levels in cord blood.", "results_summary": "DHA supplementation at 500 mg/day in GDM women did not significantly alter neonatal metabolic biomarkers (leptin, adiponectin, IGF-1) but was associated with higher birth weight z scores. Cord blood adiponectin levels were lower in GDM pregnancies compared to euglycemic controls.", "population_specificity": "Singleton pregnant women with de novo GDM diagnosed at 24-28 weeks of gestation.", "effective_dosage": "500 mg DHA per day", "study_duration": "From randomization (24-28 weeks of gestation) until delivery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:20.621511+00:00"}
{"study_id": 10753, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether omega-3 supplementation (including DHA) improves the vascular benefits of HDLs and endothelial function in hypertriglyceridemic patients.", "results_summary": "The study found that DHA and EPA supplementation significantly improved endothelial function, reduced triglycerides, and increased HDL-cholesterol and HDL-phospholipids. HDLs became enriched with EPA and DHA, showing an improved anti-inflammatory profile, though in vitro results did not replicate the endothelial benefits.", "population_specificity": "18 hypertriglyceridemic patients without clinical symptoms of coronary heart disease.", "effective_dosage": "380 mg DHA and 460 mg EPA, twice daily.", "study_duration": "5 weeks of treatment followed by a 4-week washout.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:21.800401+00:00"}
{"study_id": 10755, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine if supranutritional levels of DHA and calcidiol impair growth performance or metabolism in broiler chickens and to assess their combined effects on lipid profiles and bone properties.", "results_summary": "The study found that high levels of DHA and calcidiol improved growth performance (10-11% higher body weight gain), reduced cholesterol and triglyceride concentrations in plasma and tissues (8-54% lower), and enhanced bone properties (8-24% stronger tibial breaking strength) without adverse effects.", "population_specificity": "Day-old Cornish chicks (broiler chickens)", "effective_dosage": "1% DHA-rich Aurantiochytrium (1.2 g DHA/kg diet) in Exp. 1; 0.33-0.66% DHA-rich oil (1.5-3.0 g DHA/kg diet) in Exp. 2", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:23.468344+00:00"}
{"study_id": 10756, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether dietary docosahexaenoic acid (DHA) supplementation could improve liver health in Nile tilapia by reducing fat deposition and liver damage induced by D-galactosamine (D-GalN) and lipopolysaccharides (LPS).", "results_summary": "DHA supplementation reduced visceral somatic index, liver lipid content, and serum/liver triglyceride concentrations in Nile tilapia. It also decreased liver injury markers (alanine aminotransferase and aspartate transaminase) and downregulated genes linked to inflammation and apoptosis via the TLR4 pathway.", "population_specificity": "Nile tilapia (Oreochromis niloticus), average initial weight 2.0 \u00b1 0.1 g.", "effective_dosage": "1%, 2%, and 4% DHA-supplemented diets.", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:25.835996+00:00"}
{"study_id": 10758, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether differences in erythrocyte membrane DHA levels correlate with clinical and biological outcomes in stabilized schizophrenia patients.", "results_summary": "Patients with lower DHA levels (DHA-) had more hospitalizations, poorer quality of life, and higher interleukin-6 and cortisol levels compared to those with normal DHA levels (DHAn). The study suggests membrane lipid composition may help identify subgroups for targeted interventions.", "population_specificity": "Stabilized schizophrenia patients (N=37, split into DHA- [N=19] and DHAn [N=18] groups).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:26.515530+00:00"}
{"study_id": 10757, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether docosahexaenoic acid (DHA) could enhance the anticancer effects of the menadione/ascorbate (M/A) combination by increasing reactive oxygen species (ROS) production and affecting ATP levels in cancer cells.", "results_summary": "The study found that DHA significantly enhanced the anticancer effects of M/A by increasing mitochondrial oxidative stress and accelerating ATP depletion in leukemic lymphocytes. The triple combination (M/A/DHA) showed higher antiproliferative activity and cytotoxicity compared to M/A or DHA alone.", "population_specificity": "Leukemic lymphocyte Jurkat cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:27.059195+00:00"}
{"study_id": 10759, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Docosahexaenoic Acid (DHA) enhances the neuroprotective effects of Necrostatin-1s in an MPTP-induced Parkinson\u2019s disease mouse model by reducing neuroinflammation and oxidative stress.", "results_summary": "DHA, when combined with Nec-1s, increased neuroprotection, improved survival of dopaminergic neurons, and reduced inflammatory cytokines (IL-1\u03b2 and TNF-\u03b1), though DHA alone had minimal impact on RIP-1 expression.", "population_specificity": "BALB/c mice with MPTP-induced Parkinson\u2019s disease.", "effective_dosage": "300 mg/kg/day, orally.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:28.610953+00:00"}
{"study_id": 186766, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of docosahexaenoic acid (DHA) in reducing inflammation and mitigating chronic lung diseases, including asthma, COPD, and interstitial lung disease, as well as its effects in vulnerable populations.", "results_summary": "The study found that DHA and other n-3 PUFAs may reduce inflammation and promote resolution of inflammation, potentially benefiting chronic lung diseases. It also highlighted their role in vulnerable groups like children, the elderly, and those with obesity.", "population_specificity": "General population, with specific focus on pre/postnatal children, elderly, and individuals with obesity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:29.277859+00:00"}
{"study_id": 186765, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers aimed to determine the impact of omega-3 PUFA (including Docosahexaenoic Acid) supplementation on depression symptoms and remission in children and adolescents, compared to placebo or other controls.", "results_summary": "Omega-3 PUFA supplementation may slightly reduce self-reported depression symptoms, but the evidence is very uncertain. It showed little to no effect on depression remission, attrition, or adverse effects, with no serious adverse events reported.", "population_specificity": "Males and females aged 19 years or younger with diagnosed depression.", "effective_dosage": "Not specified in the abstract.", "study_duration": "10 to 16 weeks (median: 12 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:29.413753+00:00"}
{"study_id": 186770, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether n-3 PUFAs, including docosahexaenoic acid, could prevent depressive recurrence and reduce symptoms in euthymic patients with late-life depression.", "results_summary": "The study found that n-3 PUFAs significantly reduced the risk of depression recurrence but did not significantly improve depressive or anxiety symptoms or inflammatory markers compared to placebo.", "population_specificity": "Euthymic patients with late-life depression (39 participants).", "effective_dosage": "1.2 g per day of eicosapentaenoic acid and 1 g of docosahexaenoic acid.", "study_duration": "52 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:30.746228+00:00"}
{"study_id": 186772, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review current evidence on the role of omega-3 fatty acids, particularly docosahexaenoic acid (DHA), in preventing and treating depressive disorders.", "results_summary": "The study found that DHA and EPA have antidepressant effects linked to neuroinflammation modulation, neurotransmitter function, and neuroplasticity, but clinical trial results were inconsistent, with some showing significant symptom reduction and others minimal impact. Factors like dosage, EPA-to-DHA ratio, and baseline nutritional status influenced outcomes.", "population_specificity": "Individuals with depressive disorders (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:32.134249+00:00"}
{"study_id": 186773, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of omega-3 fatty acids, including docosahexaenoic acid, on weight, lean body/skeletal mass, and health-related quality of life in patients with advanced non-small cell lung cancer and cancer cachexia.", "results_summary": "The study found that supplementation with omega-3 fatty acids significantly increased weight and health-related quality of life scores but did not significantly affect lean body/skeletal mass. The results were based on a meta-analysis of six clinical trials.", "population_specificity": "Patients with advanced non-small cell lung cancer and cancer cachexia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:34.993153+00:00"}
{"study_id": 186775, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether prenatal DHA supplementation improves pregnancy outcomes, specifically focusing on birth weight.", "results_summary": "The meta-analysis found that DHA supplementation (450-800 mg/day) significantly increased infant birth weight, with strong statistical significance (P = .00001). The study included nine RCTs involving 5710 subjects, supporting the efficacy of DHA in this context.", "population_specificity": "Pregnant women in the latter half of pregnancy.", "effective_dosage": "450-800 mg/day", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:35.409435+00:00"}
{"study_id": 186774, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of fish oil (containing DHA and EPA) on triglyceride levels, lipidomic profiles, and gut microbiota in patients with type 2 diabetes and hypertriglyceridemia.", "results_summary": "Fish oil significantly reduced triglycerides compared to corn oil, altered serum lipid profiles by reducing low-unsaturated TG species and increasing DHA/EPA-containing species, and showed minor effects on gut microbiota. Baseline microbial features predicted triglyceride response better than phenotypic or lipidomic features.", "population_specificity": "309 Chinese patients with type 2 diabetes and hypertriglyceridemia.", "effective_dosage": "4 g fish oil daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:35.883471+00:00"}
{"study_id": 186777, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the modulatory and anti-inflammatory effects of EPA and DHA on noncommunicable diet-related diseases.", "results_summary": "EPA and DHA supplementation showed beneficial effects on triglycerides, cholesterol, insulin resistance, blood pressure, liver enzymes, inflammatory markers, oxidative stress, mitochondrial function, plasma lipoproteins, and cardiovascular risk reduction.", "population_specificity": "Patients with diet-related disorders (noncommunicable diseases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:37.161411+00:00"}
{"study_id": 186776, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antisteatotic effects of docosahexaenoic acid (DHA) and its efficacy in reducing liver fat accumulation in metabolic dysfunction-associated steatotic liver disease (MASLD).", "results_summary": "The study found that DHA, particularly when administered as phospholipids or wax esters, showed greater efficacy against MASLD compared to traditional forms like triacylglycerols or ethyl esters. The effects depended on dosage, duration, and the lipid class used for supplementation.", "population_specificity": "Overweight/obese patients and preclinical animal models with obesity and hepatic steatosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:37.517993+00:00"}
{"study_id": 186779, "supplement_id": 1089, "safety_score": "75", "efficacy_score": 68, "quality_score": 82, "study_goal": "The researchers aimed to determine the relationship between docosahexaenoic acid (DHA) and cognitive effects, ventricular volume, and adverse events in Alzheimer's disease (AD) patients.", "results_summary": "The study found that DHA, as part of n-3-PUFA supplementation, showed reduced progression of cognitive decline on the CDR scale but no significant differences in other cognitive measures or ventricular volume. Adverse events were primarily gastrointestinal symptoms.", "population_specificity": "Adult patients with Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:37.906698+00:00"}
{"study_id": 186782, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the inconsistent effects of docosahexaenoic acid (DHA) on cancer risk and explore its potential mechanisms, particularly focusing on resolvins and the role of ALOX15 in carcinogenesis.", "results_summary": "The study found inconsistent effects of DHA on cancer risk, with resolvins showing antitumorigenic potential but no significant increase in target tissue levels with supplementation. The loss of ALOX15 in cancers may impair DHA metabolism and resolvin formation, suggesting a need for further research.", "population_specificity": "Not specified (general human population, with focus on colorectal cancer).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:40.533590+00:00"}
{"study_id": 186783, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the role of docosahexaenoic acid (DHA) in maternal nutrition and its impact on fetal and infant neurodevelopment.", "results_summary": "The study found that DHA is crucial for children's cognitive, motor, speech, and socio-emotional development, with deficiencies linked to adverse outcomes like premature birth and intrauterine growth restriction. Adequate intake supports healthy brain development.", "population_specificity": "Pregnant women and their infants (fetal and infant neurodevelopment focus).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:40.629849+00:00"}
{"study_id": 186785, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to summarize the effects of parenteral fish oil (containing Docosahexaenoic Acid) on neurodevelopment in preterm infants.", "results_summary": "The study found mixed results, with randomized controlled trials showing no significant effects on neurodevelopmental outcomes, while some cohort studies reported possible benefits. The evidence was limited by methodological heterogeneity and study design limitations.", "population_specificity": "Preterm infants (born less than 37 weeks' gestation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:43.644872+00:00"}
{"study_id": 186787, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 30, "quality_score": 75, "study_goal": "To investigate the effect of re-esterified triglyceride (rTG) \u03c9-3 fatty acid supplementation, including docosahexaenoic acid, on dry eye disease (DED) associated with meibomian gland dysfunction (MGD).", "results_summary": "The study found no statistically significant benefit of rTG \u03c9-3 supplementation in improving symptoms of DED associated with MGD compared to grape-seed oil. No safety concerns or adverse events related to the supplement were reported.", "population_specificity": "Patients with DED associated with MGD (mean age 50.6 years, 78% female).", "effective_dosage": "1680 mg eicosapentaenoic acid and 560 mg docosahexaenoic acid daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:45.235031+00:00"}
{"study_id": 186789, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the effects of \u03b1-linolenic acid (ALA) supplementation on metabolic syndrome (MetS) and its conversion to docosahexaenoic acid (DHA), focusing on mechanisms and outcomes.", "results_summary": "The study found inconsistent effects of ALA supplementation on MetS components, with some positive impacts likely mediated through its conversion to EPA and DHA, influencing inflammation, insulin sensitivity, and lipid metabolism. Direct effects of ALA versus its metabolites (EPA and DHA) were noted as important distinctions.", "population_specificity": "Humans with metabolic syndrome (MetS) or related conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:46.297950+00:00"}
{"study_id": 186792, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of Docosahexaenoic Acid (DHA) as a treatment for Alzheimer's Disease (AD) among other natural compounds.", "results_summary": "DHA showed cognitive improvement potential in some cases, though these effects may not extend to AD. It was identified as one of the most promising natural compounds for AD treatment among the 13 reviewed.", "population_specificity": "Alzheimer's Disease patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:46.612051+00:00"}
{"study_id": 186788, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of docosahexaenoic acid (DHA) supplementation, combined with dietary intervention, on reducing triglyceride levels and improving metabolic parameters in individuals with hypertriglyceridemia.", "results_summary": "The study found that DHA supplementation, alongside dietary counseling, significantly reduced triglyceride levels (18.2%), LDL cholesterol (19.8%), and insulin resistance (31.8%) in the hypertriglyceridemia group compared to controls. These improvements were clinically meaningful and statistically significant.", "population_specificity": "Individuals with elevated plasma triglyceride concentrations (\u22651.7 mmol/L) or elevated fasting glucose (\u22655.6 < 7.0 mmol/L).", "effective_dosage": "3.5 g/day (combined eicosapentaenoic acid and docosahexaenoic acid).", "study_duration": "10 weeks (with a 10-week follow-up).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:47.323271+00:00"}
{"study_id": 186790, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether enteral supplementation of docosahexaenoic acid (DHA) and arachidonic acid (ArA) could reduce the incidence of severe retinopathy of prematurity (ROP) in very preterm infants.", "results_summary": "Early enteral supplementation of ArA (100 mg/kg/d) and DHA (50 mg/kg/d) until term equivalent age reduced severe ROP incidence by 50%. The study suggests that optimizing nutrition, particularly DHA and ArA, may promote growth and mitigate ROP risk in preterm infants.", "population_specificity": "Very preterm infants at risk of retinopathy of prematurity (ROP).", "effective_dosage": "DHA 50 mg/kg/day and ArA 100 mg/kg/day.", "study_duration": "Until term equivalent age.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:47.985871+00:00"}
{"study_id": 186796, "supplement_id": 1089, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether higher doses of DHA, closer to fetal accumulation rates, improve development and health outcomes in preterm infants compared to doses equivalent to breast milk levels.", "results_summary": "The study suggests that higher DHA doses, combined with arachidonic acid, may benefit brain maturation, long-term cognitive function, and retinopathy prevention in preterm infants, though neonatal morbidity risks remain under investigation. Meta-analyses do not indicate significant safety concerns.", "population_specificity": "Preterm infants", "effective_dosage": "Equivalent to estimated fetal accumulation rate (specific amount not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:49.139561+00:00"}
{"study_id": 186797, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how plasma concentrations of EPA and DHA are modulated by sex, BMI, and APOE4 status after \u03c9-3 FA supplementation.", "results_summary": "The study found significant increases in plasma EPA and DHA concentrations in both NEFA and PL pools after supplementation, with higher EPA levels in APOE4 carriers, females, and individuals with BMI \u226425. No factors influenced DHA and EPA responses in the NEFA pool.", "population_specificity": "Participants in a randomized, double-blind, placebo-controlled trial.", "effective_dosage": "DHA 0.8 g and EPA 1.7 g daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:49.626639+00:00"}
{"study_id": 186798, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the effect of n-3 PUFA, including docosahexaenoic acid (DHA), on cognitive function in middle-aged or older adults without dementia.", "results_summary": "The study found that n-3 PUFA supplementation, particularly with daily intake exceeding 500 mg, showed a beneficial trend on executive function within the first 12 months, especially in individuals with higher baseline blood DHA+EPA levels. The effect was more pronounced with up to 420 mg of EPA.", "population_specificity": "Middle-aged or older adults (aged 40+ years) without dementia.", "effective_dosage": "Daily intake exceeding 500 mg of n-3 PUFA, up to 420 mg of EPA.", "study_duration": "3 to 36 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:53.602280+00:00"}
{"study_id": 186800, "supplement_id": 1089, "safety_score": "75", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the pulmonary outcomes of enteral supplementation with AA and DHA in extremely preterm infants, focusing on bronchopulmonary dysplasia (BPD) severity.", "results_summary": "Supplementation with AA:DHA was not associated with increased BPD severity or respiratory support needs, but higher AA levels correlated with reduced BPD severity. The study had limited statistical power and suggested further research on AA and DHA's role in lung development.", "population_specificity": "Extremely preterm infants", "effective_dosage": "AA (100 mg/kg/day) and DHA (50 mg/kg/day)", "study_duration": "From birth until term age", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:54.600102+00:00"}
{"study_id": 186799, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of FADS gene variants and prenatal DHA supplementation on offspring cardiometabolic health at age 11, including interactions with diet quality.", "results_summary": "The study found no association between FADS haplotypes and metabolic syndrome (MetS) score, nor did prenatal DHA supplementation modify this association. However, an interaction was observed between offspring FADS SNP rs174602 and current dietary polyunsaturated fatty acid intake on MetS score.", "population_specificity": "Offspring (n = 203) of females who participated in a randomized controlled trial of DHA supplementation during pregnancy.", "effective_dosage": "400 mg/d", "study_duration": "From midgestation to delivery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:54.600858+00:00"}
{"study_id": 186804, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether n-3 PUFAs supplementation, including docosahexaenoic acid, improves cognitive impairment in first-diagnosed, drug-na\u00efve depressed patients.", "results_summary": "N-3 PUFAs supplementation showed a small but statistically significant improvement in immediate memory but no significant differences in other cognitive subscales compared to placebo. Both groups exhibited cognitive improvements over time, likely due to antidepressant treatment.", "population_specificity": "First-diagnosed, drug-na\u00efve depressed outpatients treated with venlafaxine (n=72).", "effective_dosage": "2.4 g/d of fish oil (960 mg docosahexaenoic acid, 1440 mg eicosapentaenoic acid).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:57.273958+00:00"}
{"study_id": 186807, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the association between serum DHA and EPA levels, dietary intakes, and supplement use during pregnancy.", "results_summary": "Regular supplement use (\u22655 times per week) and higher fish and shellfish intake were associated with elevated serum DHA and EPA levels in pregnant women during the second and third trimesters.", "population_specificity": "Pregnant women in their second and third trimesters at a university hospital in Tokyo, Japan.", "effective_dosage": "Not specified (frequency of supplement use \u22655 times per week noted).", "study_duration": "Past month (assessed via questionnaire).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:57.481949+00:00"}
{"study_id": 186805, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of maternal fish oil (containing omega-3 LCPUFA) intake from the 21st week of pregnancy to 30 days postpartum on infant neurodevelopment and growth at 9 and 12 months.", "results_summary": "The study found no statistically significant impact of omega-3 supplementation on neurodevelopmental domains, growth parameters, or maternal serum fatty acid profiles, except for DHA. Neurodevelopmental problems were rare and slightly more frequent in the placebo group.", "population_specificity": "Pregnant women from the 21st week of pregnancy to 30 days postpartum and their infants at 9 and 12 months old, in a population with low marine product consumption.", "effective_dosage": "Not specified", "study_duration": "From the 21st week of pregnancy to 30 days postpartum", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:57.923880+00:00"}
{"study_id": 186811, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether EPA, DHA, or their combination enhances recovery from exercise-induced muscle damage compared to a placebo.", "results_summary": "DHA supplementation improved leg press performance and reduced muscle soreness compared to placebo, with similar benefits observed for EPA. The combination of EPA + DHA did not clearly enhance recovery and may have blunted the effects seen with individual supplementation.", "population_specificity": "30 male participants", "effective_dosage": "4 g\u00b7d -1", "study_duration": "7 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:57.978819+00:00"}
{"study_id": 186803, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the cognitive effects of single and multiple nutrient interventions, including Docosahexaenoic Acid (DHA), in patients with mild cognitive impairment (MCI).", "results_summary": "DHA, when combined with folic acid (FA), showed a moderate effect on global cognitive function (SMD = 0.58). However, FA alone was more effective than the FA-DHA combination. DHA also improved memory function and attention in MCI patients.", "population_specificity": "Patients with mild cognitive impairment (MCI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:58.780699+00:00"}
{"study_id": 186812, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine whether Docosahexaenoic Acid could help control atherosclerosis, a primary cause of cardiovascular disease.", "results_summary": "The abstract does not provide specific results regarding Docosahexaenoic Acid's effects.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided in the abstract.", "study_duration": "Not provided in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:00.485369+00:00"}
{"study_id": 186813, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the health benefits of \u03c9-3 PUFAs, particularly Docosahexaenoic Acid, and emphasize the importance of maintaining a balanced \u03c9-6 to \u03c9-3 ratio.", "results_summary": "\u03c9-3 PUFAs, including Docosahexaenoic Acid, exhibit protective effects against diabetes-related complications, COVID-19 symptoms, and various inflammatory and neurological disorders. They also highlight the need for a balanced \u03c9-6 to \u03c9-3 ratio to prevent adverse health conditions.", "population_specificity": "General human population, with specific mentions of diabetes and COVID-19 patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:03.617965+00:00"}
{"study_id": 186815, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether high-dose docosahexaenoic acid (DHA) supplementation improves cognitive outcomes in infants born <29 weeks' gestation.", "results_summary": "The study found no significant differences in cognitive, IQ, or behavior scores between high-DHA and standard-DHA groups at seven years, though a transient benefit was observed at 18 months. The results provide limited support for DHA supplementation in extremely preterm infants.", "population_specificity": "Infants born <29 weeks' gestation.", "effective_dosage": "High-DHA (~1% total fatty acids) vs. standard-DHA (~0.3% total fatty acids).", "study_duration": "Not explicitly stated in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:04.982695+00:00"}
{"study_id": 186817, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the role of docosahexaenoic acid (DHA) in preventing cardiovascular disease (CVD) events and cognitive decline, with a focus on sex and racial differences.", "results_summary": "Higher intake of nonfried and fatty fish, as well as higher plasma levels of DHA and EPA, were associated with lower CVD risk in women and Black individuals. DHA supplementation showed cognitive benefits, particularly in women and when initiated before cognitive decline.", "population_specificity": "Women, Black individuals, Asians, and general populations in prospective studies and randomized controlled trials.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:05.995333+00:00"}
{"study_id": 186818, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of Docosahexaenoic Acid (DHA) on cognitive decline, particularly focusing on its interaction with the ApoE genotype and potential benefits for ApoE4 carriers.", "results_summary": "The study suggests that early DHA supplementation may benefit cognitively normal older adults carrying the ApoE4 gene, but its effectiveness is limited once Alzheimer's disease develops. ApoE4 non-carriers may experience greater benefits compared to ApoE4 carriers at later stages.", "population_specificity": "Older adults, particularly those with the ApoE4 allele and cognitively normal individuals or those with Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:06.894616+00:00"}
{"study_id": 186822, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to study the lipid profile of mature erythrocyte membranes (LPMEM) in professional female football players, focusing on changes in docosahexaenoic acid (DHA) levels during the competitive season.", "results_summary": "The study observed a significant increase in DHA levels in female football players during the competitive season, suggesting altered fatty acid metabolism due to athletic activity. The findings highlight the potential of membrane lipidomics for personalized nutritional strategies.", "population_specificity": "Professional female football players from the Athletic Club (Bilbao) in the first division of the Spanish league.", "effective_dosage": "Not specified", "study_duration": "Three consecutive seasons (2019-2020, 2020-2021, and 2021-2022)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:07.447041+00:00"}
{"study_id": 186823, "supplement_id": 1089, "safety_score": "75", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to provide a meta-analytic review of the adverse effects of omega-3 PUFA supplementation, including docosahexaenoic acid, in human subjects.", "results_summary": "The study found that omega-3 PUFAs, including docosahexaenoic acid, were associated with higher odds of diarrhea, dysgeusia, and bleeding tendency but lower rates of back pain compared to placebo. No serious adverse events were reported.", "population_specificity": "Human subjects in randomized controlled trials (RCTs).", "effective_dosage": "Prescription omega-3 PUFAs (RxOME3FAs) averaged 3056.38 \u00b1 1113.28 mg/d, while generic omega-3 PUFAs (OME3FAs) averaged 2315.92 \u00b1 1725.61 mg/d.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:08.524474+00:00"}
{"study_id": 186824, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of LCPUFA-\u03c93 (DHA and EPA) supplementation on body composition changes in children with acute lymphoblastic leukemia (ALL) during remission and after three months of supplementation.", "results_summary": "The study found that LCPUFA-\u03c93 supplementation reduced lean body mass (LBM) loss compared to the placebo group, with significant increases in DHA and EPA concentrations in the LCPUFA-\u03c93 group. LBM at remission correlated positively with increased DHA and EPA levels in erythrocytes.", "population_specificity": "Children aged 3-13 years with newly diagnosed acute lymphoblastic leukemia (ALL).", "effective_dosage": "100 mg/kg of body weight/day (225 mg DHA, 45 mg EPA).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:09.041694+00:00"}
{"study_id": 186825, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine the effect of omega-3 long chain polyunsaturated fatty acids (including Docosahexaenoic Acid) on prostaglandin levels and pain severity in women with dysmenorrhoea, as well as identify adverse side effects.", "results_summary": "The meta-analysis showed a large effect of omega-3 supplementation in reducing dysmenorrhoea pain and analgesic use, with few mild adverse effects reported. However, no studies measured prostaglandin levels, and the overall study quality was neutral due to methodological limitations.", "population_specificity": "Women with dysmenorrhoea (n=881).", "effective_dosage": "300-1800 mg daily.", "study_duration": "2-3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:09.836829+00:00"}
{"study_id": 186826, "supplement_id": 1089, "safety_score": "30", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to assess the risk and potential mediators of atrial fibrillation (AF) and 'micro-AF' from n-3 PUFA supplementation in post-myocardial infarction (MI) patients.", "results_summary": "The study found that n-3 PUFA supplementation increased the risk of AF and 'micro-AF' in post-MI patients, with a higher incidence in the treatment group (11.9%) compared to placebo (6.5%). Changes in serum EPA (but not DHA) mediated 65% of the association between n-3 PUFA and AF risk.", "population_specificity": "Post-myocardial infarction patients aged 70-82 years with no prior history of AF.", "effective_dosage": "1.8 g/day of EPA/DHA.", "study_duration": "2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:13.715417+00:00"}
{"study_id": 186827, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to examine the effects of daily omega-3 fatty acids (including docosahexaenoic acid) and Vitamin D on electrophysiological measures via ECG in the context of arrhythmias.", "results_summary": "The abstract does not specify the results regarding docosahexaenoic acid's effects, only that it was part of the intervention studied for potential associations with arrhythmias.", "population_specificity": "Participants in the VITAL trial (specific demographics not provided in the abstract).", "effective_dosage": "380 mg of docosahexaenoic acid per day (as part of a 1 g omega-3 FA formulation).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:14.361512+00:00"}
{"study_id": 186828, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine if a combination of LCPUFAs (including DHA) and lutein/zeaxanthin could improve memory function in healthy older individuals with memory complaints.", "results_summary": "The study found that LCPUFAs + LZ supplementation did not significantly improve memory function in healthy older individuals overall but showed improvement in those with cognitive decline.", "population_specificity": "Healthy older Japanese individuals with memory complaints, including subgroups with cognitive decline.", "effective_dosage": "Not specified in the abstract.", "study_duration": "24 weeks in Trial 1 and 12 weeks in Trial 2.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:14.641930+00:00"}
{"study_id": 186829, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine if prenatal DHA supplementation modifies the relationship between maternal weight gain and offspring fat mass and distribution at 24 months of age.", "results_summary": "The abstract does not provide results; it describes the study design and objectives. The study will measure offspring body composition and adipose tissue distribution at multiple time points.", "population_specificity": "Pregnant women and their offspring, specifically those exposed to excessive gestational weight gain.", "effective_dosage": "1000 mg or 200 mg daily prenatal DHA supplement.", "study_duration": "From the first trimester of pregnancy until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:15.547519+00:00"}
{"study_id": 186830, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the relationship between DHA intake during pregnancy and its effects on pregnancy complications and offspring neurodevelopment.", "results_summary": "The study found limited and controversial evidence for DHA's protective effects on pregnancy complications, except for preterm birth and gestational diabetes mellitus. Additional DHA supplementation may improve long-term neurodevelopmental outcomes in offspring.", "population_specificity": "Pregnant women", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:16.112095+00:00"}
{"study_id": 186831, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the benefits of Docosahexaenoic Acid (DHA) during pregnancy and postpartum, focusing on its potential to prevent preterm birth (PTB) and associated complications, while addressing dosage, safety, and mechanistic pathways.", "results_summary": "The study suggests that DHA consumption may help maintain healthy pregnancy and reduce PTB risks, but mixed clinical outcomes and unclear dosage requirements highlight the need for individualized dosing based on blood concentrations.", "population_specificity": "Pregnant women and postpartum individuals, particularly in regions with high preterm birth rates like India.", "effective_dosage": "Suggested daily intake of 250-300 mg, but individualized dosing based on blood concentrations is recommended.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:18.451465+00:00"}
{"study_id": 186833, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how neonatal growth velocity affects the association between birth weight and neurodevelopmental outcomes in preterm infants whose mothers were supplemented with docosahexaenoic acid (DHA) or placebo.", "results_summary": "The study found that postnatal growth velocity partially mediated the relationship between birth weight and neurodevelopmental outcomes, with stronger effects in infants with lower birth weight. Increased growth velocity was associated with improved cognitive and language scores, particularly in the lowest birth weight percentile group.", "population_specificity": "Breastfed infants born at <29 weeks of gestation.", "effective_dosage": "Not specified in the abstract.", "study_duration": "During the neonatal period (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:19.257560+00:00"}
{"study_id": 186832, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether the increased risk of bronchopulmonary dysplasia (BPD) associated with high-dose DHA supplementation in preterm children diminishes the cognitive benefits (IQ improvement) of DHA.", "results_summary": "The study found that DHA supplementation improved IQ by 3.45 points despite increasing BPD risk, with no significant indirect effect of BPD on IQ. Most of the IQ benefit occurred independently of BPD.", "population_specificity": "Children born at less than 29 weeks' gestation.", "effective_dosage": "60 mg/kg/day", "study_duration": "From the first 3 days of enteral feeds until 36 weeks' postmenstrual age or discharge home.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:19.264099+00:00"}
{"study_id": 186834, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to examine the rationale for using \u03c93 polyunsaturated fatty acids (PUFAs), including Docosahexaenoic Acid, in the therapy of nonalcoholic fatty liver disease (NAFLD).", "results_summary": "The abstract suggests that NAFLD severity is associated with reduced hepatic C, implying a potential role for \u03c93 PUFAs in treatment, but specific findings on Docosahexaenoic Acid's effects are not detailed.", "population_specificity": "Obese and type 2 diabetic individuals with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:22.758023+00:00"}
{"study_id": 186836, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review evidence on how genetic, epigenetic, gut microbiota, and habitual omega-3 intake factors influence individual variability in triglyceride response to omega-3 supplementation, particularly DHA.", "results_summary": "The study found inconsistent results in omega-3 supplementation's effect on CVD risk, with potential benefits mediated by reduced inflammation, oxidative stress, and triglyceride levels, though individual responses vary significantly.", "population_specificity": "Not specified (general population with focus on CVD risk)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:22.821356+00:00"}
{"study_id": 186835, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the impact of dietary supplementation with docosahexaenoic acid (DHA) combined with scaling and root planing (SRP) in untreated periodontitis stage III and IV.", "results_summary": "Patients treated with omega-3 PUFAs (including DHA) showed short-term improvements in clinical parameters like bleeding on probing (BOP), clinical attachment level (CAL), and closed pockets, as well as reduced periodontal bacteria counts, but these benefits diminished by 6 months except for lower BOP rates.", "population_specificity": "40 patients with untreated periodontitis stage III and IV.", "effective_dosage": "High-dose (specific amount not mentioned in abstract).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:23.984673+00:00"}
{"study_id": 186838, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of \u03c9-3 fatty acid supplementation, including docosahexaenoic acid (DHA), on cardiovascular outcomes in patients with diabetes.", "results_summary": "The meta-analysis found that \u03c9-3 fatty acid supplementation reduced cardiovascular disease (CVD) risk in diabetic patients, but EPA alone was effective while EPA plus DHA was not.", "population_specificity": "Patients with diabetes", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:25.658218+00:00"}
{"study_id": 186837, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between dietary PUFAs (including docosahexaenoic acid) intake, nutritional status, and sarcopenia outcomes in older adults with sarcopenia.", "results_summary": "Docosahexaenoic acid status was positively associated with appendicular lean mass (aLM), and some omega-3 PUFAs intake and status markers were positively associated with step count and quality of life scores.", "population_specificity": "Sarcopenic older adults (>65 years, 9 males/20 females, mean age 76.3 \u00b1 5.4 years).", "effective_dosage": "Not specified (baseline dietary intake was 1.99 \u00b1 0.99 g/d for total omega-3, below recommended levels).", "study_duration": "Not specified (baseline cross-sectional analysis of an ongoing trial).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:26.327448+00:00"}
{"study_id": 186839, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the clinical and biological effects of long-chain \u03c9-3 PUFAs, including Docosahexaenoic Acid (DHA), on cardiovascular outcomes through a meta-analysis of major RCTs.", "results_summary": "LC \u03c9-3 PUFA supplementation, including DHA, showed beneficial effects on CV death and fatal or nonfatal MI, but not on stroke, all-cause mortality, or heart failure hospitalization. Notably, both EPA/DHA combinations and EPA alone increased the risk of new-onset atrial fibrillation.", "population_specificity": "143,410 participants from 17 RCTs, with \u2265500 participants per study and \u22651 year follow-up.", "effective_dosage": "Not specified", "study_duration": "\u22651 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:29.529715+00:00"}
{"study_id": 186841, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the longitudinal relationships of omega-3 fatty acid intake, particularly docosahexaenoic acid (DHA), with the risk of Alzheimer's disease, dementia, or cognitive decline.", "results_summary": "Long-term omega-3 fatty acid supplementation, especially DHA, was associated with a 64% reduced risk of Alzheimer's disease in the ADNI cohort. A meta-analysis of 48 studies further supported that dietary DHA intake could lower the risk of all-cause dementia or cognitive decline by approximately 20%.", "population_specificity": "1,135 participants without dementia (mean age 73 years) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, plus a meta-analysis of 103,651 participants from 48 longitudinal studies.", "effective_dosage": "Not specified", "study_duration": "6-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:29.593829+00:00"}
{"study_id": 186842, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of high-dose n-3 PUFA (including docosahexaenoic acid) on platelet function and inflammatory markers in individuals with familial hypercholesterolemia.", "results_summary": "The study found no significant treatment effect of high-dose n-3 PUFA on platelet function or inflammatory markers in the studied population.", "population_specificity": "Genetically verified heterozygous familial hypercholesterolemia patients (ages 18-75) on stable statin treatment for over 12 months.", "effective_dosage": "1520 mg docosahexaenoic acid and 1840 mg eicosapentaenoic acid daily, administered in four capsules.", "study_duration": "Two three-month treatment periods separated by a three-month washout.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:29.626859+00:00"}
{"study_id": 186844, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the antioxidant and anti-inflammatory effects of DHA supplementation in patients with keratoconus and its impact on corneal topography and plasma biomarkers.", "results_summary": "The DHA-treated group showed significant improvements in corneal topography variables (astigmatism axis, asphericity coefficient, intraocular pressure) and favorable changes in oxidative stress and inflammatory markers (TAC, MDA, GSH/GSSG ratio, IL-4, IL-6, VEGF-A) compared to controls.", "population_specificity": "Patients with keratoconus stages I-III (75% men, mean age 31 years).", "effective_dosage": "1000 mg/day", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:31.989992+00:00"}
{"study_id": 186843, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 85, "study_goal": "The researchers aimed to examine whether enteral supplementation with high-dose DHA during the neonatal period reduces the risk of bronchopulmonary dysplasia (BPD) in preterm infants born at less than 29 weeks' gestation.", "results_summary": "High-dose DHA supplementation was not associated with overall BPD risk but showed an inverse association in studies using a stringent BPD definition and with moderate-to-severe BPD. The findings suggest high-dose DHA should not be recommended for BPD prevention in very preterm infants.", "population_specificity": "Preterm infants born at less than 29 weeks' gestation.", "effective_dosage": "Minimum of 40 mg/kg/d or breast milk/formula with at least 0.4% of total fatty acids as DHA.", "study_duration": "Neonatal period (specific duration not detailed in abstract).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:32.999868+00:00"}
{"study_id": 186846, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether fish oil supplementation (FOS), containing docosahexaenoic acid (DHA), enhances resistance exercise training (RET)-induced strength and hypertrophy adaptations in young, recreationally trained adults.", "results_summary": "The study found that FOS improved absolute and relative upper-body strength and relative lower-body strength more than placebo when combined with RET. No significant adverse effects were reported, but safety was not a primary focus.", "population_specificity": "Young, recreationally trained male and female adults.", "effective_dosage": "Not specified in the abstract.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:34.444428+00:00"}
{"study_id": 186845, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between Omega-3 Index (O3I) and school grades, and the effect of krill oil supplementation (containing DHA and EPA) on school grades in adolescents with low baseline O3I.", "results_summary": "The study found no significant effect of krill oil supplementation on subject grades or standardized mathematics test performance, despite a small increase in O3I. Baseline O3I showed a significant association with English grades and a trend with Dutch grades, but no associations were found after 12 months.", "population_specificity": "Adolescents with a low Omega-3 Index at baseline.", "effective_dosage": "400 mg EPA + DHA per day for the first three months (Cohort 1), then 800 mg EPA + DHA per day for the next nine months; Cohort 2 received 800 mg EPA + DHA per day for the entire 12 months.", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:34.861095+00:00"}
{"study_id": 186847, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the dose-response effect of DHA supplementation on red blood cell incorporation and the Omega-3 Index in collegiate American-style football players.", "results_summary": "The study found a significant dose and time interaction, with all supplement groups showing greater DHA in RBC compared to placebo. The 6 g\u00b7d\u207b\u00b9 group achieved the highest Omega-3 Index (>8%) in 8 weeks, twice as fast as the 4 g\u00b7d\u207b\u00b9 group.", "population_specificity": "Collegiate American-style football players", "effective_dosage": "2, 4, or 6 g\u00b7d\u207b\u00b9 of DHA", "study_duration": "27 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:35.782888+00:00"}
{"study_id": 186848, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "To evaluate the effect of antenatal omega-3 (DHA) supplementation on child development and behavior during the first six months of life.", "results_summary": "The omega-3 group showed an increase in developmental scores over time, while the placebo group did not. The placebo group had greater difficulty with routine than the omega-3 group, suggesting a beneficial behavioral effect of DHA supplementation.", "population_specificity": "Low-risk pregnant women with gestational age between 22 and 24 weeks.", "effective_dosage": "1440 mg/day of DHA", "study_duration": "Supplemented until childbirth", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:37.498358+00:00"}
{"study_id": 186850, "supplement_id": 1089, "safety_score": "80", "efficacy_score": 30, "quality_score": 85, "study_goal": "To determine if higher-dose DHA supplementation in preterm infants affects growth, body composition, and blood pressure at 7 years corrected age, and whether effects differ by sex or birth weight.", "results_summary": "High-DHA supplementation showed no significant effects on growth, body composition, or blood pressure overall or by sex. However, infants in the high-DHA group had a higher relative risk of obesity, though this finding requires cautious interpretation due to small sample size.", "population_specificity": "Infants born before 33 weeks\u2019 gestation.", "effective_dosage": "High-DHA (\u22481% total fatty acids) vs. standard-DHA (\u22480.3% total fatty acids).", "study_duration": "From age 2\u22124 days until term corrected age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:39.089929+00:00"}
{"study_id": 186849, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether adherence to a high dose of docosahexaenoic acid (DHA) reduced early preterm birth (EPTB) and preterm birth (PTB) rates, particularly in women with low baseline DHA levels.", "results_summary": "Adherence to high-dose DHA (1000 mg/day) significantly reduced EPTB and PTB, with the strongest effects observed in women with low baseline DHA levels. Bayesian analysis showed a 65% reduction in EPTB (from 3.45% to 1.2%) and consistent reductions in PTB before 35, 36, and 37 weeks.", "population_specificity": "1,100 women with singleton pregnancies enrolled before 20 weeks' gestation.", "effective_dosage": "200 mg/day (baseline) + 800 mg/day (randomized high dose) or placebo.", "study_duration": "From enrollment (<20 weeks' gestation) until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:40.553528+00:00"}
{"study_id": 186851, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if assessing DHA intake could identify pregnancies that benefit from high-dose DHA supplementation to reduce preterm birth risk.", "results_summary": "The study found that pregnant women with low DHA intake (<150 mg/day) had a lower probability of early preterm birth (1.4% vs. 3.9%) and preterm birth (11.3% vs. 14.8%) when assigned to high-dose DHA supplementation. The DHA-FFQ effectively identified pregnancies that benefited most from high-dose DHA.", "population_specificity": "Pregnant women (n=1310) at approximately 16.8 weeks gestation.", "effective_dosage": "Standard dose (200 mg/day) or high dose (800 or 1000 mg/day).", "study_duration": "From enrollment (~16.8 weeks gestation) until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:41.906992+00:00"}
{"study_id": 186853, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to investigate evidence of DHA deficiency in human populations and its potential association with child development disorders and neurological conditions.", "results_summary": "The abstract suggests that low blood levels of DHA in some westernized populations may be linked to sub-optimal neural function, but it does not provide conclusive evidence of deficiency or efficacy of supplementation. The proposition is supported by the supplement industry, but the abstract does not detail specific outcomes.", "population_specificity": "Human populations, particularly westernized groups with low blood DHA levels.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:42.055935+00:00"}
{"study_id": 186855, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to compare the cardiovascular effects of EPA alone versus EPA combined with DHA, focusing on outcomes in high-risk patients.", "results_summary": "The study found that high-dose EPA alone significantly reduced cardiovascular events, while combinations of EPA and DHA showed no benefit. Trials like JELIS and REDUCE-IT supported EPA's efficacy, whereas others (ASCEND, VITAL, STRENGTH, OMEMI) did not demonstrate benefits for EPA+DHA.", "population_specificity": "Patients with elevated triglycerides at high cardiovascular risk, particularly statin-treated individuals.", "effective_dosage": "High-dose EPA (specific amount not detailed in abstract).", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:43.648797+00:00"}
{"study_id": 186856, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the common and differential effects of EPA and DHA on plasma lipids and lipoproteins and assess the metabolic mechanisms behind these effects.", "results_summary": "DHA lowered plasma TG concentrations, increased LDL-C concentrations, and affected enzyme activities differently than EPA, with sex-specific variations observed in lipoprotein metabolism.", "population_specificity": "21 older (>50 y) men and postmenopausal women with some characteristics of metabolic syndrome and low-grade chronic inflammation.", "effective_dosage": "3 g/d pure DHA (as ethyl ester, \u226597% purity)", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:44.725555+00:00"}
{"study_id": 186854, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the cognitive effects of n-3 fatty acid supplementation, including docosahexaenoic acid (DHA), through a scoping review of randomized controlled trials (RCTs).", "results_summary": "The review found that 43.6% of RCTs reported positive cognitive outcomes with n-3 FA supplementation, with the highest efficacy (66.7%) observed in adults with mild cognitive impairments (MCI). However, results were inconsistent across different populations and cognitive tests.", "population_specificity": "Non-cognitively impaired middle-aged adults, non-cognitively impaired older adults, adults with subjective memory complaints, adults with MCI, and people with diagnosed dementia or other cognitive changes.", "effective_dosage": "79 mg/day - 5200 mg/day of EPA + DHA", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:44.898599+00:00"}
{"study_id": 186857, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy of omega-3 PUFAs, including docosahexaenoic acid, as monotherapy for major depressive disorder (MDD).", "results_summary": "The study found no clear evidence of omega-3 PUFAs' effectiveness in treating MDD, though supplementation may benefit specific populations. Eight RCTs met inclusion criteria but did not demonstrate significant therapeutic effects.", "population_specificity": "Patients with major depressive disorder (MDD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:46.445324+00:00"}
{"study_id": 186858, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To determine the effects of a 250 mg/day DHA supplement of vegetable origin on serum fatty acid profiles in lacto-ovo vegetarian, vegan, and omnivorous adults.", "results_summary": "The DHA supplement significantly increased serum DHA levels across all diet groups, with the highest increase observed in vegans. It also improved the n-6/n-3 fatty acid ratio but decreased docosapentaenoic and docosatetraenoic acids.", "population_specificity": "Healthy lacto-ovo vegetarian, vegan, and omnivorous adults (n=116).", "effective_dosage": "250 mg/day", "study_duration": "5-week intervention periods separated by a 5-week washout.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:48.884558+00:00"}
{"study_id": 186859, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether omega-3 fatty acid supplementation, including Docosahexaenoic Acid, improves clinical outcomes in periodontitis patients when used alongside non-surgical periodontal therapy.", "results_summary": "The study found that omega-3 supplementation significantly improved probing depth and clinical attachment loss compared to the control group, though bleeding index improvements were not significantly different. The intervention group showed greater overall clinical improvement.", "population_specificity": "30 patients with periodontitis", "effective_dosage": "1000 mg natural fish oil soft-gels daily (containing 120 mg Docosahexaenoic Acid)", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:49.438974+00:00"}
